| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRB2 TBXA2R GPR4 LPAR3 TNFRSF25 NPBWR2 FLT3 NPR3 DRD3 DRD4 HTR1B HTR1D MAS1L HTR5A LPAR5 GPER1 HLA-DPA1 GPR82 MC4R OR6C3 TMEM63B TMEM63C P2RY8 FGFRL1 S1PR2 GRID1 OR11H12 PTCH1 PKD1L3 GRM4 LPAR1 BDKRB1 FCRL6 ADGRL4 ADGRG6 S1PR5 ADORA2A OR4C3 KISS1R OR11H1 GPR153 PTCH2 P2RY10 ANTXR1 OR4C12 LPAR2 TACR1 TACR3 LGR6 ADGRE1 OR11H2 GPR45 CNR1 CNR2 | 7.47e-25 | 1353 | 155 | 54 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | TBXA2R GPR4 LPAR3 NPBWR2 NPR3 DRD3 DRD4 HTR1B HTR1D MAS1L HTR5A LPAR5 GPER1 GPR82 MC4R OR6C3 P2RY8 S1PR2 OR11H12 GRM4 LPAR1 BDKRB1 ADGRL4 ADGRG6 S1PR5 ADORA2A OR4C3 KISS1R OR11H1 GPR153 P2RY10 OR4C12 LPAR2 TACR1 TACR3 LGR6 ADGRE1 OR11H2 GPR45 CNR1 CNR2 | 5.74e-21 | 884 | 155 | 41 | GO:0004930 |
| GeneOntologyMolecularFunction | transporter activity | GABRB2 HTR1B XKR9 RHBDF2 TMEM94 ATP8A2 SLC22A23 TRPC1 OTOP2 TMEM63B TMEM63C GRID1 TMC4 SLC35F1 SLC7A7 PKD1L3 ABCC6 GJD4 SLC7A9 SLC6A4 SLC22A9 SLC7A1 SIDT2 SLC44A1 SLC41A3 MLC1 SLC22A14 SLC16A14 SLC49A3 MFSD8 ATG9A SLC5A12 ABCC2 SLC51A SVOP SLC29A4 SLC6A14 SLC44A3 SLC23A3 SLC22A31 | 1.99e-14 | 1289 | 155 | 40 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRB2 HTR1B TMEM94 SLC22A23 TRPC1 OTOP2 TMEM63B TMEM63C GRID1 TMC4 SLC35F1 SLC7A7 PKD1L3 ABCC6 GJD4 SLC7A9 SLC6A4 SLC22A9 SLC7A1 SIDT2 SLC44A1 SLC41A3 MLC1 SLC22A14 SLC16A14 SLC49A3 MFSD8 SLC5A12 ABCC2 SLC51A SVOP SLC29A4 SLC6A14 SLC44A3 SLC23A3 SLC22A31 | 8.89e-13 | 1180 | 155 | 36 | GO:0022857 |
| GeneOntologyMolecularFunction | serotonin binding | 3.23e-08 | 13 | 155 | 5 | GO:0051378 | |
| GeneOntologyMolecularFunction | bioactive lipid receptor activity | 1.08e-07 | 16 | 155 | 5 | GO:0045125 | |
| GeneOntologyMolecularFunction | amine binding | 4.86e-07 | 21 | 155 | 5 | GO:0043176 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 9.72e-07 | 133 | 155 | 9 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.49e-06 | 140 | 155 | 9 | GO:0001653 | |
| GeneOntologyMolecularFunction | lysophosphatidic acid receptor activity | 4.54e-06 | 5 | 155 | 3 | GO:0070915 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC7A7 SLC7A9 SLC22A9 SLC7A1 SLC16A14 SLC5A12 ABCC2 SLC51A SLC29A4 SLC6A14 | 5.35e-06 | 208 | 155 | 10 | GO:0005342 |
| GeneOntologyMolecularFunction | peptidyltransferase activity | 9.02e-06 | 6 | 155 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 9.02e-06 | 6 | 155 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.30e-05 | 100 | 155 | 7 | GO:0030594 | |
| GeneOntologyMolecularFunction | G protein-coupled serotonin receptor activity | 2.29e-05 | 22 | 155 | 4 | GO:0004993 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 2.50e-05 | 8 | 155 | 3 | GO:0103068 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC7A7 SLC7A9 SLC22A9 SLC7A1 SLC16A14 SLC5A12 ABCC2 SLC51A SLC6A14 | 3.54e-05 | 207 | 155 | 9 | GO:0046943 |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 3.72e-05 | 9 | 155 | 3 | GO:0036374 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 4.58e-05 | 83 | 155 | 6 | GO:0015101 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC7A7 SLC7A9 SLC22A9 SLC7A1 SLC22A14 SLC16A14 SLC5A12 ABCC2 SLC51A SLC6A14 | 1.00e-04 | 293 | 155 | 10 | GO:0008514 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRB2 HTR1B TMEM94 TRPC1 OTOP2 TMEM63B TMEM63C GRID1 TMC4 PKD1L3 SLC6A4 SLC41A3 MLC1 MFSD8 SLC5A12 SLC29A4 SLC6A14 | 1.48e-04 | 793 | 155 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | hedgehog receptor activity | 1.79e-04 | 3 | 155 | 2 | GO:0008158 | |
| GeneOntologyMolecularFunction | cannabinoid receptor activity | 1.79e-04 | 3 | 155 | 2 | GO:0004949 | |
| GeneOntologyMolecularFunction | tachykinin receptor activity | 1.79e-04 | 3 | 155 | 2 | GO:0004995 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity, coupled via Gi/Go | 1.79e-04 | 3 | 155 | 2 | GO:0001591 | |
| GeneOntologyMolecularFunction | channel activity | GABRB2 HTR1B TRPC1 OTOP2 TMEM63B TMEM63C GRID1 TMC4 PKD1L3 GJD4 SLC6A4 MLC1 MFSD8 | 2.36e-04 | 525 | 155 | 13 | GO:0015267 |
| GeneOntologyMolecularFunction | omega peptidase activity | 2.39e-04 | 16 | 155 | 3 | GO:0008242 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRB2 HTR1B TRPC1 OTOP2 TMEM63B TMEM63C GRID1 TMC4 PKD1L3 GJD4 SLC6A4 MLC1 MFSD8 | 2.41e-04 | 526 | 155 | 13 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRB2 HTR1B TRPC1 OTOP2 TMEM63B TMEM63C GRID1 TMC4 PKD1L3 SLC6A4 MLC1 MFSD8 | 2.52e-04 | 459 | 155 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 2.83e-04 | 41 | 155 | 4 | GO:0008227 | |
| GeneOntologyMolecularFunction | smoothened binding | 3.56e-04 | 4 | 155 | 2 | GO:0005119 | |
| GeneOntologyMolecularFunction | hedgehog family protein binding | 3.56e-04 | 4 | 155 | 2 | GO:0097108 | |
| GeneOntologyMolecularFunction | anandamide 8,9 epoxidase activity | 3.56e-04 | 4 | 155 | 2 | GO:0062187 | |
| GeneOntologyMolecularFunction | anandamide 11,12 epoxidase activity | 3.56e-04 | 4 | 155 | 2 | GO:0062188 | |
| GeneOntologyMolecularFunction | steroid 21-monooxygenase activity | 3.56e-04 | 4 | 155 | 2 | GO:0004509 | |
| GeneOntologyMolecularFunction | progesterone 21-hydroxylase activity | 3.56e-04 | 4 | 155 | 2 | GO:0106309 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | TMEM94 ABCC6 SLC7A9 SLC6A4 SLC22A9 SLC44A1 SLC41A3 SLC16A14 SLC5A12 ABCC2 SLC29A4 SLC6A14 | 3.57e-04 | 477 | 155 | 12 | GO:0022804 |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 4.75e-04 | 20 | 155 | 3 | GO:0070003 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 4.75e-04 | 20 | 155 | 3 | GO:0015174 | |
| GeneOntologyMolecularFunction | osmolarity-sensing monoatomic cation channel activity | 5.90e-04 | 5 | 155 | 2 | GO:1990760 | |
| GeneOntologyMolecularFunction | dopamine neurotransmitter receptor activity | 5.90e-04 | 5 | 155 | 2 | GO:0004952 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 7.61e-04 | 53 | 155 | 4 | GO:0008188 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRB2 HTR1B TMEM94 TRPC1 OTOP2 TMEM63B TMEM63C PKD1L3 ABCC6 SLC6A4 SLC41A3 MFSD8 SLC5A12 ABCC2 SLC6A14 | 8.42e-04 | 758 | 155 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | osmosensor activity | 8.80e-04 | 6 | 155 | 2 | GO:0005034 | |
| GeneOntologyMolecularFunction | anandamide 14,15 epoxidase activity | 8.80e-04 | 6 | 155 | 2 | GO:0062189 | |
| GeneOntologyMolecularFunction | anandamide epoxidase activity | 8.80e-04 | 6 | 155 | 2 | GO:0062186 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor | 1.23e-03 | 7 | 155 | 2 | GO:0016723 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 1.63e-03 | 8 | 155 | 2 | GO:0015431 | |
| GeneOntologyMolecularFunction | choline transmembrane transporter activity | 1.63e-03 | 8 | 155 | 2 | GO:0015220 | |
| GeneOntologyMolecularFunction | sphingosine-1-phosphate receptor activity | 1.63e-03 | 8 | 155 | 2 | GO:0038036 | |
| GeneOntologyMolecularFunction | amine transmembrane transporter activity | 2.08e-03 | 9 | 155 | 2 | GO:0005275 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.15e-03 | 70 | 155 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC7A9 SLC6A4 SLC22A9 SLC44A1 SLC41A3 SLC16A14 SLC5A12 SLC6A14 | 2.23e-03 | 296 | 155 | 8 | GO:0015291 |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 2.30e-03 | 34 | 155 | 3 | GO:0042910 | |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 2.59e-03 | 10 | 155 | 2 | GO:0043225 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 2.77e-03 | 75 | 155 | 4 | GO:0098960 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 2.94e-03 | 37 | 155 | 3 | GO:0042923 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 3.67e-03 | 40 | 155 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | monoamine transmembrane transporter activity | 3.75e-03 | 12 | 155 | 2 | GO:0008504 | |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 3.75e-03 | 12 | 155 | 2 | GO:0019534 | |
| GeneOntologyMolecularFunction | L-arginine transmembrane transporter activity | 4.41e-03 | 13 | 155 | 2 | GO:0061459 | |
| GeneOntologyMolecularFunction | aromatic amino acid transmembrane transporter activity | 4.41e-03 | 13 | 155 | 2 | GO:0015173 | |
| GeneOntologyMolecularFunction | FAD binding | 4.81e-03 | 44 | 155 | 3 | GO:0071949 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 5.32e-03 | 90 | 155 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | HTR1B TMEM94 TRPC1 OTOP2 TMEM63B TMEM63C PKD1L3 SLC6A4 SLC41A3 SLC5A12 SLC29A4 SLC6A14 | 5.71e-03 | 664 | 155 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 5.88e-03 | 15 | 155 | 2 | GO:0008559 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 7.27e-03 | 51 | 155 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | magnesium ion transmembrane transporter activity | 8.44e-03 | 18 | 155 | 2 | GO:0015095 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 8.44e-03 | 18 | 155 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions | 8.44e-03 | 18 | 155 | 2 | GO:0016722 | |
| GeneOntologyMolecularFunction | hormone binding | 8.52e-03 | 103 | 155 | 4 | GO:0042562 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | TBXA2R GPR4 LPAR3 NPR3 DRD3 DRD4 HTR1B HTR1D HTR5A GPER1 MC4R S1PR2 GRM4 LPAR1 ADGRL4 ADGRG6 S1PR5 ADORA2A LPAR2 ADGRE1 CNR1 CNR2 | 2.82e-16 | 286 | 154 | 22 | GO:0007188 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | TBXA2R GPR4 LPAR3 NPBWR2 NPR3 DRD3 DRD4 HTR1B HTR1D MAS1L HTR5A LPAR5 GPER1 TRPC1 GPR82 MC4R OR6C3 P2RY8 S1PR2 OR11H12 GRM4 LPAR1 BDKRB1 ADGRL4 ADGRG6 S1PR5 ADORA2A OR4C3 KISS1R OR11H1 GPR153 P2RY10 OR4C12 LPAR2 TACR1 TACR3 LGR6 ADGRE1 OR11H2 GPR45 CNR1 CNR2 | 2.71e-15 | 1395 | 154 | 42 | GO:0007186 |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | TBXA2R GPR4 LPAR3 DRD3 HTR5A GPER1 MC4R S1PR2 LPAR1 ADGRL4 ADGRG6 S1PR5 ADORA2A LPAR2 ADGRE1 CNR1 CNR2 | 7.56e-14 | 191 | 154 | 17 | GO:0007189 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRB2 LPAR3 TCAF1 DRD3 DRD4 HTR1B GPER1 TMEM94 SLC22A23 TRPC1 OTOP2 TMEM63B TMEM63C GRID1 TMC4 PKD1L3 BDKRB1 ABCC6 SLC6A4 ADORA2A SLC22A9 SLC41A3 MLC1 STEAP3 MFSD8 SLC5A12 ABCC2 G6PD SLC29A4 CNR1 SLC6A14 SLC22A31 | 6.75e-09 | 1374 | 154 | 32 | GO:0006811 |
| GeneOntologyBiologicalProcess | organic acid transport | DRD3 DRD4 HTR1B CLTRN SLC7A7 ABCC6 SLC7A9 ADORA2A SLC22A9 SLC7A1 KISS1R SLC16A14 SLC5A12 ABCC2 SLC51A SLC29A4 SLC6A14 | 1.31e-08 | 412 | 154 | 17 | GO:0015849 |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | TBXA2R GPR4 NPR3 HTR1B HTR1D GPER1 SLC6A4 ADORA2A SLC7A1 SLC44A1 CLDN5 TACR1 ABCC2 G6PD SLC29A4 | 4.80e-08 | 344 | 154 | 15 | GO:0003018 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | DRD3 DRD4 HTR1B CLTRN SLC7A7 ABCC6 SLC7A9 ADORA2A SLC22A9 SLC7A1 KISS1R SLC16A14 SLC5A12 ABCC2 SLC51A SLC6A14 | 7.77e-08 | 410 | 154 | 16 | GO:0046942 |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting serotonin receptor signaling pathway | 1.03e-07 | 7 | 154 | 4 | GO:0007198 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 2.61e-07 | 86 | 154 | 8 | GO:0007193 | |
| GeneOntologyBiologicalProcess | organic anion transport | DRD3 DRD4 HTR1B CLTRN SLC7A7 ABCC6 SLC7A9 ADORA2A SLC22A9 SLC7A1 KISS1R SLC22A14 SLC16A14 SLC5A12 ABCC2 SLC51A SLC6A14 | 3.24e-07 | 515 | 154 | 17 | GO:0015711 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | 3.51e-07 | 61 | 154 | 7 | GO:0007187 | |
| GeneOntologyBiologicalProcess | circulatory system process | TBXA2R GPR4 NPR3 DRD3 HTR1B HTR1D GPER1 TRPC1 BDKRB1 SLC6A4 ADORA2A SLC7A1 SLC44A1 CLDN5 TACR1 TACR3 ABCC2 G6PD SLC29A4 CNR1 | 5.81e-07 | 733 | 154 | 20 | GO:0003013 |
| GeneOntologyBiologicalProcess | amine metabolic process | 1.73e-06 | 148 | 154 | 9 | GO:0009308 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRB2 TCAF1 DRD3 DRD4 GPER1 TMEM94 TRPC1 OTOP2 TMEM63B TMEM63C GRID1 TMC4 PKD1L3 BDKRB1 ABCC6 SLC6A4 SLC41A3 MLC1 STEAP3 MFSD8 ABCC2 G6PD SLC29A4 SLC6A14 | 2.74e-06 | 1115 | 154 | 24 | GO:0034220 |
| GeneOntologyBiologicalProcess | secretion | MICAL1 NPR3 DRD3 DRD4 HTR1B HTR1D RHBDF2 GPER1 CLTRN TRPC1 TM7SF3 MC4R TMEM63B ARFGEF2 ARFGEF1 GRM4 SLC6A4 ADORA2A SIDT2 KISS1R STEAP3 TACR1 ABCC2 SLC51A CNR1 | 4.01e-06 | 1221 | 154 | 25 | GO:0046903 |
| GeneOntologyBiologicalProcess | amine transport | 8.92e-06 | 137 | 154 | 8 | GO:0015837 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid biosynthetic process | 1.28e-05 | 69 | 154 | 6 | GO:0170038 | |
| GeneOntologyBiologicalProcess | positive regulation of Rho protein signal transduction | 1.31e-05 | 41 | 154 | 5 | GO:0035025 | |
| GeneOntologyBiologicalProcess | organic cation transport | 1.35e-05 | 145 | 154 | 8 | GO:0015695 | |
| GeneOntologyBiologicalProcess | L-amino acid biosynthetic process | 1.39e-05 | 70 | 154 | 6 | GO:0170034 | |
| GeneOntologyBiologicalProcess | response to cocaine | 1.51e-05 | 71 | 154 | 6 | GO:0042220 | |
| GeneOntologyBiologicalProcess | export from cell | MICAL1 DRD3 DRD4 HTR1B HTR1D RHBDF2 GPER1 CLTRN TRPC1 TM7SF3 MC4R ARFGEF2 ARFGEF1 GRM4 SLC6A4 ADORA2A SIDT2 KISS1R STEAP3 TACR1 ABCC2 SLC29A4 CNR1 | 1.56e-05 | 1153 | 154 | 23 | GO:0140352 |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 1.62e-05 | 21 | 154 | 4 | GO:0000097 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | DRD3 DRD4 HTR1B PTCH1 SLC6A4 ADORA2A SLC44A1 SLC5A12 ABCC2 SLC51A SLC29A4 CNR1 | 1.64e-05 | 358 | 154 | 12 | GO:0015850 |
| GeneOntologyBiologicalProcess | synaptic transmission, GABAergic | 1.92e-05 | 74 | 154 | 6 | GO:0051932 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, GABAergic | 2.09e-05 | 45 | 154 | 5 | GO:0032228 | |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 2.16e-05 | 202 | 154 | 9 | GO:0035296 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 2.16e-05 | 202 | 154 | 9 | GO:0097746 | |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 2.22e-05 | 8 | 154 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 2.24e-05 | 203 | 154 | 9 | GO:0035150 | |
| GeneOntologyBiologicalProcess | G protein-coupled serotonin receptor signaling pathway | 2.37e-05 | 23 | 154 | 4 | GO:0098664 | |
| GeneOntologyBiologicalProcess | alpha-amino acid biosynthetic process | 2.41e-05 | 77 | 154 | 6 | GO:1901607 | |
| GeneOntologyBiologicalProcess | monoamine transport | 2.66e-05 | 116 | 154 | 7 | GO:0015844 | |
| GeneOntologyBiologicalProcess | response to ethanol | 2.88e-05 | 161 | 154 | 8 | GO:0045471 | |
| GeneOntologyBiologicalProcess | blood circulation | TBXA2R GPR4 NPR3 DRD3 HTR1B HTR1D GPER1 TRPC1 BDKRB1 SLC6A4 ADORA2A CLDN5 TACR1 TACR3 G6PD CNR1 | 2.88e-05 | 648 | 154 | 16 | GO:0008015 |
| GeneOntologyBiologicalProcess | signal release | DRD3 DRD4 HTR1B HTR1D GPER1 CLTRN TRPC1 TM7SF3 MC4R GRM4 SLC6A4 ADORA2A SIDT2 KISS1R TACR1 CNR1 | 3.16e-05 | 653 | 154 | 16 | GO:0023061 |
| GeneOntologyBiologicalProcess | positive regulation of uterine smooth muscle contraction | 3.32e-05 | 9 | 154 | 3 | GO:0070474 | |
| GeneOntologyBiologicalProcess | response to alkaloid | 4.31e-05 | 125 | 154 | 7 | GO:0043279 | |
| GeneOntologyBiologicalProcess | secretion by cell | MICAL1 DRD3 DRD4 HTR1B HTR1D RHBDF2 GPER1 CLTRN TRPC1 TM7SF3 MC4R ARFGEF2 ARFGEF1 GRM4 SLC6A4 ADORA2A SIDT2 KISS1R STEAP3 TACR1 CNR1 | 4.42e-05 | 1064 | 154 | 21 | GO:0032940 |
| GeneOntologyBiologicalProcess | amino acid biosynthetic process | 4.52e-05 | 86 | 154 | 6 | GO:0008652 | |
| GeneOntologyBiologicalProcess | copulation | 4.59e-05 | 27 | 154 | 4 | GO:0007620 | |
| GeneOntologyBiologicalProcess | dopamine metabolic process | 4.67e-05 | 53 | 154 | 5 | GO:0042417 | |
| GeneOntologyBiologicalProcess | peptide modification | 4.71e-05 | 10 | 154 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 4.71e-05 | 10 | 154 | 3 | GO:1901750 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 5.01e-05 | 128 | 154 | 7 | GO:0050795 | |
| GeneOntologyBiologicalProcess | response to estradiol | 5.01e-05 | 128 | 154 | 7 | GO:0032355 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 6.39e-05 | 133 | 154 | 7 | GO:0007200 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 6.45e-05 | 11 | 154 | 3 | GO:0006751 | |
| GeneOntologyBiologicalProcess | dopamine transport | 6.66e-05 | 57 | 154 | 5 | GO:0015872 | |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure | 7.86e-05 | 59 | 154 | 5 | GO:0045777 | |
| GeneOntologyBiologicalProcess | catecholamine transport | 8.38e-05 | 96 | 154 | 6 | GO:0051937 | |
| GeneOntologyBiologicalProcess | regulation of uterine smooth muscle contraction | 8.55e-05 | 12 | 154 | 3 | GO:0070472 | |
| GeneOntologyBiologicalProcess | response to histamine | 8.55e-05 | 12 | 154 | 3 | GO:0034776 | |
| GeneOntologyBiologicalProcess | regulation of serotonin secretion | 8.55e-05 | 12 | 154 | 3 | GO:0014062 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 8.55e-05 | 12 | 154 | 3 | GO:1901748 | |
| GeneOntologyBiologicalProcess | serotonin transport | 9.13e-05 | 32 | 154 | 4 | GO:0006837 | |
| GeneOntologyBiologicalProcess | ammonium ion metabolic process | 9.13e-05 | 32 | 154 | 4 | GO:0097164 | |
| GeneOntologyBiologicalProcess | uterine smooth muscle contraction | 1.10e-04 | 13 | 154 | 3 | GO:0070471 | |
| GeneOntologyBiologicalProcess | amino acid transport | 1.11e-04 | 195 | 154 | 8 | GO:0006865 | |
| GeneOntologyBiologicalProcess | alpha-amino acid metabolic process | 1.16e-04 | 251 | 154 | 9 | GO:1901605 | |
| GeneOntologyBiologicalProcess | behavior | GPI DRD3 DRD4 HTR1B HTR1D LPAR5 ATP8A2 MC4R GRID1 GRM4 LGI4 SLC6A4 ADORA2A CLDN5 MFSD8 TACR1 TACR3 CNR1 | 1.21e-04 | 891 | 154 | 18 | GO:0007610 |
| GeneOntologyBiologicalProcess | response to alcohol | 1.22e-04 | 312 | 154 | 10 | GO:0097305 | |
| GeneOntologyBiologicalProcess | synaptic signaling | GABRB2 LPAR3 DRD3 DRD4 HTR1B HTR1D HTR5A GPER1 TRPC1 S1PR2 GRID1 GRM4 SLC6A4 ADORA2A KISS1R TACR1 NRG3 CNR1 CNR2 | 1.26e-04 | 976 | 154 | 19 | GO:0099536 |
| GeneOntologyBiologicalProcess | synaptic transmission, dopaminergic | 1.31e-04 | 35 | 154 | 4 | GO:0001963 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | DRD3 DRD4 HTR1B HTR1D GPER1 S1PR2 GRID1 GRM4 SLC6A4 ADORA2A KISS1R TACR1 NRG3 CNR1 CNR2 | 1.37e-04 | 663 | 154 | 15 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | DRD3 DRD4 HTR1B HTR1D GPER1 S1PR2 GRID1 GRM4 SLC6A4 ADORA2A KISS1R TACR1 NRG3 CNR1 CNR2 | 1.39e-04 | 664 | 154 | 15 | GO:0099177 |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle contraction | 1.46e-04 | 36 | 154 | 4 | GO:0045987 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 1.47e-04 | 259 | 154 | 9 | GO:0006836 | |
| GeneOntologyBiologicalProcess | serotonin biosynthetic process from tryptophan | 1.65e-04 | 3 | 154 | 2 | GO:0006587 | |
| GeneOntologyBiologicalProcess | neurotransmitter reuptake | 1.81e-04 | 38 | 154 | 4 | GO:0098810 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 2.04e-04 | 213 | 154 | 8 | GO:0015718 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | GABRB2 LPAR3 DRD3 DRD4 HTR1B HTR1D HTR5A GPER1 S1PR2 GRID1 GRM4 SLC6A4 ADORA2A KISS1R TACR1 NRG3 CNR1 CNR2 | 2.08e-04 | 931 | 154 | 18 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | GABRB2 LPAR3 DRD3 DRD4 HTR1B HTR1D HTR5A GPER1 S1PR2 GRID1 GRM4 SLC6A4 ADORA2A KISS1R TACR1 NRG3 CNR1 CNR2 | 2.08e-04 | 931 | 154 | 18 | GO:0007268 |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 2.13e-04 | 16 | 154 | 3 | GO:0006534 | |
| GeneOntologyBiologicalProcess | icosanoid transport | 2.17e-04 | 73 | 154 | 5 | GO:0071715 | |
| GeneOntologyBiologicalProcess | feeding behavior | 2.19e-04 | 162 | 154 | 7 | GO:0007631 | |
| GeneOntologyBiologicalProcess | sulfur amino acid metabolic process | 2.22e-04 | 40 | 154 | 4 | GO:0000096 | |
| GeneOntologyBiologicalProcess | response to amphetamine | 2.22e-04 | 40 | 154 | 4 | GO:0001975 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | GABRB2 LPAR3 DRD3 DRD4 HTR1B HTR1D HTR5A GPER1 S1PR2 GRID1 GRM4 SLC6A4 ADORA2A KISS1R TACR1 NRG3 CNR1 CNR2 | 2.31e-04 | 939 | 154 | 18 | GO:0099537 |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 2.31e-04 | 74 | 154 | 5 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 2.31e-04 | 74 | 154 | 5 | GO:0006584 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 2.63e-04 | 167 | 154 | 7 | GO:1903825 | |
| GeneOntologyBiologicalProcess | protein secretion | DRD3 DRD4 RHBDF2 GPER1 CLTRN TRPC1 TM7SF3 MC4R ADORA2A SIDT2 STEAP3 CNR1 | 2.66e-04 | 480 | 154 | 12 | GO:0009306 |
| GeneOntologyBiologicalProcess | establishment of protein localization to extracellular region | DRD3 DRD4 RHBDF2 GPER1 CLTRN TRPC1 TM7SF3 MC4R ADORA2A SIDT2 STEAP3 CNR1 | 2.82e-04 | 483 | 154 | 12 | GO:0035592 |
| GeneOntologyBiologicalProcess | vasoconstriction | 2.98e-04 | 121 | 154 | 6 | GO:0042310 | |
| GeneOntologyBiologicalProcess | biogenic amine metabolic process | 2.98e-04 | 121 | 154 | 6 | GO:0006576 | |
| GeneOntologyBiologicalProcess | protein localization to extracellular region | DRD3 DRD4 RHBDF2 GPER1 CLTRN TRPC1 TM7SF3 MC4R ADORA2A SIDT2 STEAP3 CNR1 | 3.21e-04 | 490 | 154 | 12 | GO:0071692 |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission | 3.33e-04 | 80 | 154 | 5 | GO:0050805 | |
| GeneOntologyBiologicalProcess | regulation of secretion | MICAL1 NPR3 DRD3 DRD4 HTR1B HTR1D RHBDF2 GPER1 TRPC1 TM7SF3 SLC6A4 ADORA2A SIDT2 KISS1R TACR1 CNR1 | 3.33e-04 | 801 | 154 | 16 | GO:0051046 |
| GeneOntologyBiologicalProcess | regulation of amine transport | 3.55e-04 | 125 | 154 | 6 | GO:0051952 | |
| GeneOntologyBiologicalProcess | serotonin secretion | 3.62e-04 | 19 | 154 | 3 | GO:0001820 | |
| GeneOntologyBiologicalProcess | basic amino acid transmembrane transport | 3.62e-04 | 19 | 154 | 3 | GO:1990822 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | LPAR3 DRD3 DRD4 GPER1 TMEM94 TRPC1 OTOP2 TMEM63B TMEM63C PKD1L3 BDKRB1 SLC6A4 ADORA2A SLC41A3 STEAP3 SLC5A12 ABCC2 G6PD SLC29A4 SLC6A14 | 3.96e-04 | 1157 | 154 | 20 | GO:0006812 |
| GeneOntologyBiologicalProcess | hormone transport | GPER1 CLTRN TRPC1 TM7SF3 MC4R SLC22A9 SIDT2 KISS1R TACR1 ABCC2 CNR1 | 4.13e-04 | 432 | 154 | 11 | GO:0009914 |
| GeneOntologyBiologicalProcess | regulation of blood pressure | 4.18e-04 | 237 | 154 | 8 | GO:0008217 | |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 4.24e-04 | 20 | 154 | 3 | GO:0006750 | |
| GeneOntologyBiologicalProcess | dopamine uptake | 4.24e-04 | 20 | 154 | 3 | GO:0090494 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | MICAL1 DRD3 DRD4 HTR1B HTR1D RHBDF2 GPER1 TRPC1 TM7SF3 SLC6A4 ADORA2A SIDT2 KISS1R TACR1 CNR1 | 4.42e-04 | 740 | 154 | 15 | GO:1903530 |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 4.75e-04 | 132 | 154 | 6 | GO:0035249 | |
| GeneOntologyBiologicalProcess | catecholamine uptake | 4.92e-04 | 21 | 154 | 3 | GO:0090493 | |
| GeneOntologyCellularComponent | synaptic membrane | GABRB2 DRD3 DRD4 HTR1B HTR5A GPER1 GRID1 GRM4 LPAR1 SLC6A4 ADORA2A SSPN LPAR2 ATG9A CNR1 | 3.24e-05 | 583 | 156 | 15 | GO:0097060 |
| GeneOntologyCellularComponent | presynapse | GABRB2 MICAL1 DRD4 HTR1B GPER1 ARFGEF2 S1PR2 SLC35F1 GRM4 LPAR1 SLC6A4 S1PR5 ADORA2A LINGO1 LPAR2 ATG9A SVOP SLC29A4 CNR1 | 3.49e-05 | 886 | 156 | 19 | GO:0098793 |
| GeneOntologyCellularComponent | presynaptic membrane | GABRB2 DRD4 HTR1B GPER1 GRM4 LPAR1 SLC6A4 ADORA2A LPAR2 CNR1 | 4.55e-05 | 277 | 156 | 10 | GO:0042734 |
| GeneOntologyCellularComponent | serotonergic synapse | 1.65e-04 | 3 | 156 | 2 | GO:0099154 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 2.35e-04 | 164 | 156 | 7 | GO:0098982 | |
| GeneOntologyCellularComponent | postsynaptic membrane | GABRB2 DRD3 DRD4 HTR5A GPER1 GRID1 LPAR1 SLC6A4 ADORA2A SSPN | 9.52e-04 | 405 | 156 | 10 | GO:0045211 |
| MousePheno | aminoaciduria | 1.65e-07 | 29 | 123 | 6 | MP:0003311 | |
| MousePheno | abnormal urine amino acid level | 8.03e-07 | 59 | 123 | 7 | MP:0011468 | |
| MousePheno | seminal vesicle hypoplasia | 1.15e-06 | 10 | 123 | 4 | MP:0005148 | |
| MousePheno | abnormal circulating glutathione level | 6.56e-06 | 5 | 123 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 6.56e-06 | 5 | 123 | 3 | MP:0030653 | |
| MousePheno | glutathionuria | 6.56e-06 | 5 | 123 | 3 | MP:0013730 | |
| MousePheno | increased glutathione level | 6.56e-06 | 5 | 123 | 3 | MP:0012606 | |
| MousePheno | impaired behavioral response to xenobiotic | 8.21e-06 | 83 | 123 | 7 | MP:0009747 | |
| MousePheno | aciduria | 8.37e-06 | 55 | 123 | 6 | MP:0010028 | |
| MousePheno | decreased circulating follicle stimulating hormone level | 1.10e-05 | 34 | 123 | 5 | MP:0002790 | |
| MousePheno | decreased circulating cysteine level | 2.27e-05 | 7 | 123 | 3 | MP:0030626 | |
| MousePheno | decreased cysteine level | 3.60e-05 | 8 | 123 | 3 | MP:0030623 | |
| MousePheno | epididymis hypoplasia | 3.60e-05 | 8 | 123 | 3 | MP:0004932 | |
| MousePheno | decreased follicle stimulating hormone level | 4.01e-05 | 44 | 123 | 5 | MP:0005130 | |
| MousePheno | uterus hypoplasia | 4.44e-05 | 23 | 123 | 4 | MP:0001121 | |
| MousePheno | impaired behavioral response to addictive substance | 4.48e-05 | 45 | 123 | 5 | MP:0009750 | |
| MousePheno | nervous | 5.37e-05 | 9 | 123 | 3 | MP:0008912 | |
| MousePheno | failure of copulatory plug deposition | 7.63e-05 | 10 | 123 | 3 | MP:0030983 | |
| MousePheno | ovary hypoplasia | 7.63e-05 | 10 | 123 | 3 | MP:0005158 | |
| MousePheno | disorganized placental labyrinth | 7.63e-05 | 10 | 123 | 3 | MP:0011527 | |
| MousePheno | impaired behavioral response to morphine | 7.63e-05 | 10 | 123 | 3 | MP:0009757 | |
| MousePheno | abnormal circulating estradiol level | 9.08e-05 | 52 | 123 | 5 | MP:0005183 | |
| MousePheno | abnormal circulating cysteine level | 1.04e-04 | 11 | 123 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 1.04e-04 | 11 | 123 | 3 | MP:0011130 | |
| MousePheno | abnormal follicle stimulating hormone level | 1.31e-04 | 89 | 123 | 6 | MP:0003967 | |
| MousePheno | abnormal circulating estrogen level | 1.41e-04 | 57 | 123 | 5 | MP:0003369 | |
| MousePheno | abnormal cysteine level | 1.78e-04 | 13 | 123 | 3 | MP:0030621 | |
| MousePheno | abnormal behavioral response to morphine | 1.78e-04 | 13 | 123 | 3 | MP:0020159 | |
| MousePheno | decreased glutathione level | 1.78e-04 | 13 | 123 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 1.78e-04 | 13 | 123 | 3 | MP:0012603 | |
| MousePheno | decreased circulating gonadotropin level | 1.80e-04 | 60 | 123 | 5 | MP:0003363 | |
| MousePheno | anovulation | 1.92e-04 | 33 | 123 | 4 | MP:0008869 | |
| MousePheno | priapism | 2.25e-04 | 14 | 123 | 3 | MP:0003415 | |
| MousePheno | lysinuria | 2.29e-04 | 3 | 123 | 2 | MP:0020403 | |
| MousePheno | increased behavioral withdrawal response | 2.29e-04 | 3 | 123 | 2 | MP:0009775 | |
| MousePheno | abnormal conditioned place preference behavior | 2.42e-04 | 35 | 123 | 4 | MP:0009711 | |
| MousePheno | diluted coat color | 2.45e-04 | 64 | 123 | 5 | MP:0000371 | |
| MousePheno | decreased circulating estradiol level | 3.34e-04 | 38 | 123 | 4 | MP:0005181 | |
| MousePheno | abnormal copulatory plug deposition | 3.42e-04 | 16 | 123 | 3 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 3.42e-04 | 16 | 123 | 3 | MP:0008477 | |
| MousePheno | abnormal active avoidance behavior | 4.13e-04 | 17 | 123 | 3 | MP:0002798 | |
| MousePheno | abnormal spleen red pulp morphology | 4.17e-04 | 110 | 123 | 6 | MP:0002356 | |
| MousePheno | decreased circulating estrogen level | 4.49e-04 | 41 | 123 | 4 | MP:0003371 | |
| MousePheno | argininuria | 4.55e-04 | 4 | 123 | 2 | MP:0020401 | |
| MousePheno | increased lysine level | 4.55e-04 | 4 | 123 | 2 | MP:0030721 | |
| MousePheno | abnormal amino acid level | GPR4 ATP8A2 CLTRN MC4R SLC7A7 LPAR1 ABCC6 GGT2P GGT1 GGT3P SLC7A9 GOT1L1 KISS1R MTRR | 4.83e-04 | 570 | 123 | 14 | MP:0005332 |
| MousePheno | failure of superovulation | 4.93e-04 | 18 | 123 | 3 | MP:0031422 | |
| MousePheno | abnormal penile erection | 4.93e-04 | 18 | 123 | 3 | MP:0001379 | |
| MousePheno | oocyte degeneration | 4.93e-04 | 18 | 123 | 3 | MP:0009093 | |
| MousePheno | induced hyperactivity | 4.93e-04 | 42 | 123 | 4 | MP:0008911 | |
| MousePheno | increased circulating growth hormone level | 5.81e-04 | 19 | 123 | 3 | MP:0005123 | |
| MousePheno | abnormal copulation physiology | 5.81e-04 | 19 | 123 | 3 | MP:0031627 | |
| MousePheno | decreased long bone epiphyseal plate size | 5.90e-04 | 44 | 123 | 4 | MP:0006396 | |
| MousePheno | absent estrous cycle | 5.90e-04 | 44 | 123 | 4 | MP:0009009 | |
| MousePheno | increased amino acid level | 6.51e-04 | 79 | 123 | 5 | MP:0014527 | |
| MousePheno | type IV spiral ligament fibrocyte degeneration | 7.55e-04 | 5 | 123 | 2 | MP:0004490 | |
| MousePheno | dermal hyperplasia | 7.55e-04 | 5 | 123 | 2 | MP:0004971 | |
| MousePheno | abnormal amino acid derivative level | 8.21e-04 | 125 | 123 | 6 | MP:0021145 | |
| MousePheno | abnormal long bone morphology | NPR3 TTC28 GPER1 TMEM63B FGFRL1 LINGO2 GPR108 LGI4 GGT2P GGT1 GGT3P JAG2 ANTXR1 ASCC3 SLC29A4 | 8.65e-04 | 676 | 123 | 15 | MP:0003723 |
| MousePheno | small vertebrae | 9.06e-04 | 22 | 123 | 3 | MP:0004610 | |
| MousePheno | domed cranium | 9.09e-04 | 85 | 123 | 5 | MP:0000440 | |
| MousePheno | cochlear outer hair cell degeneration | 9.59e-04 | 86 | 123 | 5 | MP:0004404 | |
| MousePheno | increased growth hormone level | 1.04e-03 | 23 | 123 | 3 | MP:0005137 | |
| MousePheno | decreased circulating pituitary hormone level | 1.12e-03 | 89 | 123 | 5 | MP:0005118 | |
| MousePheno | abnormal circulating methionine level | 1.13e-03 | 6 | 123 | 2 | MP:0030643 | |
| MousePheno | increased arginine level | 1.13e-03 | 6 | 123 | 2 | MP:0030664 | |
| MousePheno | abnormal copulation behavior | 1.18e-03 | 24 | 123 | 3 | MP:0009697 | |
| MousePheno | abnormal behavioral response to alcohol | 1.18e-03 | 24 | 123 | 3 | MP:0020157 | |
| MousePheno | abnormal social/conspecific interaction behavior | HTR1B LPAR5 SLC7A7 LGI4 GGT2P GGT1 GGT3P SLC6A4 ADORA2A KISS1R CNR1 | 1.21e-03 | 421 | 123 | 11 | MP:0002557 |
| MousePheno | abnormal coat/hair pigmentation | RHBDF2 SZT2 PRSS56 TMC4 PTCH1 GGT2P GGT1 HPS3 GGT3P UTP20 MFSD8 | 1.29e-03 | 424 | 123 | 11 | MP:0002075 |
| MousePheno | small uterus | 1.30e-03 | 92 | 123 | 5 | MP:0002637 | |
| MousePheno | abnormal sexual interaction | 1.43e-03 | 94 | 123 | 5 | MP:0002566 | |
| MousePheno | abnormal limb long bone morphology | NPR3 TTC28 GPER1 TMEM63B LINGO2 GPR108 LGI4 GGT2P GGT1 GGT3P JAG2 ASCC3 SLC29A4 | 1.47e-03 | 568 | 123 | 13 | MP:0011504 |
| MousePheno | nuclear cataract | 1.49e-03 | 26 | 123 | 3 | MP:0010254 | |
| MousePheno | impaired conditioned place preference behavior | 1.49e-03 | 26 | 123 | 3 | MP:0009712 | |
| MousePheno | abnormal hemoglobin | IL24 GPI NPR3 RHBDF2 TMEM94 MARCHF2 ARFGEF1 FGFRL1 ADGRL4 ADORA2A SLC7A1 TM9SF2 PTCH2 STEAP3 ABCC2 SVOP G6PD SLC6A14 | 1.54e-03 | 946 | 123 | 18 | MP:0001588 |
| MousePheno | abnormal type IV spiral ligament fibrocytes | 1.57e-03 | 7 | 123 | 2 | MP:0004296 | |
| MousePheno | abnormal lysine level | 1.57e-03 | 7 | 123 | 2 | MP:0030720 | |
| MousePheno | small male preputial gland | 1.57e-03 | 7 | 123 | 2 | MP:0002716 | |
| MousePheno | abnormal limb morphology | ASNSD1 FLT3 NPR3 RHBDF2 TTC28 GPER1 TMEM63B LINGO2 PTCH1 GPR108 LGI4 GGT2P GGT1 GGT3P ADGRG6 JAG2 SSPN ASCC3 SLC29A4 | 1.58e-03 | 1028 | 123 | 19 | MP:0002109 |
| Domain | G_PROTEIN_RECEP_F1_2 | TBXA2R GPR4 LPAR3 NPBWR2 DRD3 DRD4 HTR1B HTR1D MAS1L HTR5A LPAR5 GPER1 GPR82 MC4R OR6C3 P2RY8 S1PR2 OR11H12 LPAR1 BDKRB1 S1PR5 ADORA2A OR4C3 KISS1R OR11H1 GPR153 P2RY10 OR4C12 LPAR2 TACR1 TACR3 LGR6 OR11H2 GPR45 CNR1 CNR2 | 2.68e-19 | 691 | 153 | 36 | PS50262 |
| Domain | GPCR_Rhodpsn | TBXA2R GPR4 LPAR3 NPBWR2 DRD3 DRD4 HTR1B HTR1D MAS1L HTR5A LPAR5 GPER1 GPR82 MC4R OR6C3 P2RY8 S1PR2 OR11H12 LPAR1 BDKRB1 S1PR5 ADORA2A OR4C3 KISS1R OR11H1 GPR153 P2RY10 OR4C12 LPAR2 TACR1 TACR3 LGR6 OR11H2 GPR45 CNR1 CNR2 | 2.81e-19 | 692 | 153 | 36 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | TBXA2R GPR4 LPAR3 NPBWR2 DRD3 DRD4 HTR1B HTR1D MAS1L HTR5A LPAR5 GPER1 GPR82 MC4R OR6C3 P2RY8 S1PR2 OR11H12 LPAR1 BDKRB1 S1PR5 ADORA2A OR4C3 KISS1R OR11H1 GPR153 P2RY10 OR4C12 LPAR2 TACR1 TACR3 OR11H2 GPR45 CNR1 CNR2 | 8.46e-19 | 670 | 153 | 35 | IPR017452 |
| Domain | 7tm_1 | TBXA2R GPR4 LPAR3 NPBWR2 DRD3 DRD4 HTR1B HTR1D MAS1L HTR5A LPAR5 GPER1 GPR82 MC4R OR6C3 P2RY8 S1PR2 OR11H12 LPAR1 BDKRB1 S1PR5 ADORA2A OR4C3 KISS1R OR11H1 GPR153 P2RY10 OR4C12 LPAR2 TACR1 TACR3 LGR6 GPR45 CNR1 CNR2 | 1.18e-18 | 677 | 153 | 35 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | TBXA2R GPR4 LPAR3 NPBWR2 DRD3 DRD4 HTR1B HTR1D MAS1L HTR5A LPAR5 GPER1 GPR82 MC4R OR6C3 P2RY8 S1PR2 OR11H12 LPAR1 BDKRB1 S1PR5 ADORA2A OR4C3 KISS1R OR11H1 GPR153 P2RY10 OR4C12 LPAR2 TACR1 TACR3 LGR6 GPR45 CNR1 CNR2 | 1.70e-18 | 685 | 153 | 35 | PS00237 |
| Domain | 7TM_GPCR_Srsx | LPAR3 NPBWR2 DRD3 DRD4 HTR1B HTR1D MC4R S1PR2 LPAR1 ADORA2A LPAR2 CNR1 CNR2 | 7.56e-12 | 112 | 153 | 13 | SM01381 |
| Domain | LPA_rcpt | 5.39e-07 | 3 | 153 | 3 | IPR004065 | |
| Domain | MFS_dom | SLC22A23 SLC22A9 SLC22A14 SLC16A14 SLC49A3 MFSD8 SVOP SLC29A4 SLC22A31 | 1.60e-06 | 134 | 153 | 9 | IPR020846 |
| Domain | MFS | SLC22A23 SLC22A9 SLC22A14 SLC16A14 SLC49A3 MFSD8 SVOP SLC22A31 | 2.97e-06 | 108 | 153 | 8 | PS50850 |
| Domain | MFS_1 | 4.02e-05 | 77 | 153 | 6 | PF07690 | |
| Domain | MFS | 4.02e-05 | 77 | 153 | 6 | IPR011701 | |
| Domain | 5HT_rcpt | 4.37e-05 | 9 | 153 | 3 | IPR002231 | |
| Domain | FAM209 | 6.67e-05 | 2 | 153 | 2 | IPR027943 | |
| Domain | FAM209 | 6.67e-05 | 2 | 153 | 2 | PF15206 | |
| Domain | TM_rcpt_patched | 6.67e-05 | 2 | 153 | 2 | IPR004766 | |
| Domain | Cnbnoid_rcpt | 6.67e-05 | 2 | 153 | 2 | IPR002230 | |
| Domain | AA_permease_2 | 1.45e-04 | 13 | 153 | 3 | PF13520 | |
| Domain | AA/rel_permease1 | 1.45e-04 | 13 | 153 | 3 | IPR002293 | |
| Domain | GPS | 1.66e-04 | 34 | 153 | 4 | SM00303 | |
| Domain | GPS | 1.86e-04 | 35 | 153 | 4 | PF01825 | |
| Domain | RSN1_7TM | 1.99e-04 | 3 | 153 | 2 | IPR003864 | |
| Domain | Neurokn_rcpt | 1.99e-04 | 3 | 153 | 2 | IPR001681 | |
| Domain | PHM7_cyt | 1.99e-04 | 3 | 153 | 2 | IPR027815 | |
| Domain | PHM7_cyt | 1.99e-04 | 3 | 153 | 2 | PF14703 | |
| Domain | RSN1_7TM | 1.99e-04 | 3 | 153 | 2 | PF02714 | |
| Domain | Csc1_N | 1.99e-04 | 3 | 153 | 2 | IPR032880 | |
| Domain | RSN1_TM | 1.99e-04 | 3 | 153 | 2 | PF13967 | |
| Domain | MFS_sugar_transport-like | 2.08e-04 | 36 | 153 | 4 | IPR005828 | |
| Domain | Sugar_tr | 2.08e-04 | 36 | 153 | 4 | PF00083 | |
| Domain | GPS | 2.08e-04 | 36 | 153 | 4 | PS50221 | |
| Domain | GPS | 2.32e-04 | 37 | 153 | 4 | IPR000203 | |
| Domain | DUF1981 | 3.96e-04 | 4 | 153 | 2 | PF09324 | |
| Domain | Sec7_N | 3.96e-04 | 4 | 153 | 2 | IPR032691 | |
| Domain | Multidrug-R_assoc | 3.96e-04 | 4 | 153 | 2 | IPR005292 | |
| Domain | Sec7_N | 3.96e-04 | 4 | 153 | 2 | PF12783 | |
| Domain | DCB_dom | 3.96e-04 | 4 | 153 | 2 | IPR032629 | |
| Domain | DCB | 3.96e-04 | 4 | 153 | 2 | PF16213 | |
| Domain | Sec7_C | 3.96e-04 | 4 | 153 | 2 | IPR015403 | |
| Domain | S1P_rcpt | 6.56e-04 | 5 | 153 | 2 | IPR004061 | |
| Domain | Dopamine_rcpt | 6.56e-04 | 5 | 153 | 2 | IPR000929 | |
| Domain | Choline_transpo | 6.56e-04 | 5 | 153 | 2 | PF04515 | |
| Domain | Choline_transptr-like | 6.56e-04 | 5 | 153 | 2 | IPR007603 | |
| Domain | AA-permease/SLC12A_dom | 7.40e-04 | 22 | 153 | 3 | IPR004841 | |
| Domain | AA_permease | 7.40e-04 | 22 | 153 | 3 | PF00324 | |
| Domain | GGT_peptidase | 1.36e-03 | 7 | 153 | 2 | IPR000101 | |
| Domain | G_GLU_TRANSPEPTIDASE | 1.36e-03 | 7 | 153 | 2 | PS00462 | |
| Domain | G_glu_transpept | 1.36e-03 | 7 | 153 | 2 | PF01019 | |
| Domain | Ptc/Disp | 2.31e-03 | 9 | 153 | 2 | IPR003392 | |
| Domain | Patched | 2.31e-03 | 9 | 153 | 2 | PF02460 | |
| Domain | GPCR_2_secretin-like_CS | 2.68e-03 | 34 | 153 | 3 | IPR017983 | |
| Domain | ANF_lig-bd_rcpt | 3.42e-03 | 37 | 153 | 3 | IPR001828 | |
| Domain | ANF_receptor | 3.42e-03 | 37 | 153 | 3 | PF01094 | |
| Domain | Peripla_BP_I | 3.97e-03 | 39 | 153 | 3 | IPR028082 | |
| Domain | PMP22_Claudin | 4.27e-03 | 40 | 153 | 3 | PF00822 | |
| Domain | SSD | 4.90e-03 | 13 | 153 | 2 | IPR000731 | |
| Domain | SSD | 4.90e-03 | 13 | 153 | 2 | PS50156 | |
| Domain | PMP22/EMP/MP20/Claudin | 5.95e-03 | 45 | 153 | 3 | IPR004031 | |
| Domain | - | 6.53e-03 | 15 | 153 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 6.53e-03 | 15 | 153 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 6.53e-03 | 15 | 153 | 2 | IPR023394 | |
| Domain | Sec7 | 7.42e-03 | 16 | 153 | 2 | SM00222 | |
| Domain | SEC7 | 7.42e-03 | 16 | 153 | 2 | PS50190 | |
| Domain | Sec7_dom | 7.42e-03 | 16 | 153 | 2 | IPR000904 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 7.97e-03 | 50 | 153 | 3 | PS00650 | |
| Domain | 7tm_2 | 7.97e-03 | 50 | 153 | 3 | PF00002 | |
| Domain | TPR_2 | 7.97e-03 | 50 | 153 | 3 | PF07719 | |
| Domain | TPR_2 | 7.97e-03 | 50 | 153 | 3 | IPR013105 | |
| Pathway | WP_GPCRS_NONODORANT | TBXA2R LPAR3 DRD3 DRD4 HTR1B HTR1D HTR5A LPAR5 GPER1 MC4R S1PR2 GRM4 LPAR1 BDKRB1 ADGRL4 S1PR5 ADORA2A KISS1R P2RY10 LPAR2 TACR1 TACR3 ADGRE1 CNR1 CNR2 | 1.06e-20 | 266 | 107 | 25 | MM15843 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | GABRB2 TBXA2R LPAR3 NPBWR2 DRD3 DRD4 HTR1B HTR1D HTR5A MC4R P2RY8 S1PR2 GRID1 GRM4 LPAR1 BDKRB1 S1PR5 ADORA2A KISS1R P2RY10 LPAR2 TACR1 TACR3 CNR1 CNR2 | 1.84e-20 | 272 | 107 | 25 | M13380 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | TBXA2R GPR4 LPAR3 NPBWR2 DRD3 DRD4 HTR1B HTR1D HTR5A LPAR5 GPER1 MC4R S1PR2 PTCH1 GRM4 LPAR1 BDKRB1 S1PR5 ADORA2A KISS1R PTCH2 P2RY10 LPAR2 TACR1 TACR3 ADGRE1 CNR1 CNR2 | 5.28e-18 | 463 | 107 | 28 | M507 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | TBXA2R GPR4 LPAR3 NPBWR2 DRD3 DRD4 HTR1B HTR1D HTR5A LPAR5 GPER1 MC4R S1PR2 LPAR1 BDKRB1 S1PR5 ADORA2A KISS1R P2RY10 LPAR2 TACR1 TACR3 CNR1 CNR2 | 2.75e-17 | 330 | 107 | 24 | M18334 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | TBXA2R GPR4 LPAR3 DRD3 DRD4 HTR1B HTR1D HTR5A LPAR5 GPER1 MC4R S1PR2 LPAR1 BDKRB1 S1PR5 ADORA2A KISS1R P2RY10 LPAR2 TACR1 TACR3 CNR1 CNR2 | 4.30e-16 | 333 | 107 | 23 | MM14963 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | TBXA2R GPR4 LPAR3 DRD3 DRD4 HTR1B HTR1D HTR5A LPAR5 GPER1 MC4R S1PR2 GRM4 LPAR1 BDKRB1 S1PR5 ADORA2A KISS1R P2RY10 LPAR2 TACR1 TACR3 ADGRE1 CNR1 CNR2 | 1.07e-15 | 430 | 107 | 25 | MM15160 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | TBXA2R GPR4 LPAR3 NPBWR2 DRD3 DRD4 HTR1B HTR1D HTR5A LPAR5 GPER1 MC4R S1PR2 PTCH1 GRM4 LPAR1 BDKRB1 S1PR5 ADORA2A KISS1R PTCH2 P2RY10 LPAR2 TACR1 TACR3 ADGRE1 GPR45 CNR1 CNR2 | 2.89e-14 | 702 | 107 | 29 | M746 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | TBXA2R GPR4 NPBWR2 DRD3 DRD4 HTR1B HTR1D MAS1L HTR5A LPAR5 GPER1 MC4R BDKRB1 ADORA2A P2RY10 GPR45 CNR1 CNR2 | 9.08e-13 | 260 | 107 | 18 | M39397 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | TBXA2R GPR4 LPAR3 DRD3 DRD4 HTR1B HTR1D HTR5A LPAR5 GPER1 MC4R S1PR2 GRM4 LPAR1 BDKRB1 S1PR5 ADORA2A KISS1R P2RY10 LPAR2 TACR1 TACR3 ADGRE1 GPR45 CNR1 CNR2 | 1.49e-12 | 646 | 107 | 26 | MM14962 |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | LPAR3 NPBWR2 DRD3 DRD4 HTR1B HTR1D HTR5A LPAR5 GPER1 S1PR2 GRM4 LPAR1 BDKRB1 S1PR5 LPAR2 CNR1 CNR2 | 2.02e-10 | 314 | 107 | 17 | M600 |
| Pathway | REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS | 4.74e-10 | 14 | 107 | 6 | M27331 | |
| Pathway | REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS | 4.74e-10 | 14 | 107 | 6 | MM15062 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | LPAR3 DRD3 DRD4 HTR1B HTR1D HTR5A LPAR5 GPER1 S1PR2 GRM4 LPAR1 BDKRB1 S1PR5 LPAR2 CNR1 CNR2 | 5.22e-10 | 289 | 107 | 16 | MM15057 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | TBXA2R DRD3 DRD4 HTR1B HTR1D HTR5A GPER1 MC4R BDKRB1 ADORA2A GPR45 CNR1 CNR2 | 1.48e-09 | 186 | 107 | 13 | MM15994 |
| Pathway | WP_GPCRS_SMALL_LIGAND | 1.82e-07 | 18 | 107 | 5 | MM15858 | |
| Pathway | WP_SMALL_LIGAND_GPCRS | 2.45e-07 | 19 | 107 | 5 | M39728 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY | 3.84e-07 | 9 | 107 | 4 | M47732 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | TBXA2R GPR4 LPAR3 LPAR5 LPAR1 BDKRB1 KISS1R P2RY10 LPAR2 TACR1 TACR3 | 5.48e-07 | 210 | 107 | 11 | MM15043 |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | TBXA2R GPR4 LPAR3 LPAR5 LPAR1 BDKRB1 KISS1R P2RY10 LPAR2 TACR1 TACR3 | 7.58e-07 | 217 | 107 | 11 | M18437 |
| Pathway | KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY | 2.13e-06 | 13 | 107 | 4 | M47731 | |
| Pathway | WP_MONOAMINE_GPCRS | 3.33e-06 | 31 | 107 | 5 | MM15871 | |
| Pathway | WP_MONOAMINE_GPCRS | 4.60e-06 | 33 | 107 | 5 | M39585 | |
| Pathway | WP_GLUTATHIONE_AND_ONECARBON_METABOLISM | 6.21e-06 | 35 | 107 | 5 | MM15815 | |
| Pathway | REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION | 1.46e-05 | 7 | 107 | 3 | M27501 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.56e-05 | 42 | 107 | 5 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 1.56e-05 | 42 | 107 | 5 | MM14971 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY | 2.49e-05 | 23 | 107 | 4 | M47549 | |
| Pathway | WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS | 3.45e-05 | 9 | 107 | 3 | M48047 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR | 3.45e-05 | 9 | 107 | 3 | M47893 | |
| Pathway | BIOCARTA_AKAP13_PATHWAY | 3.45e-05 | 9 | 107 | 3 | MM1477 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 4.81e-05 | 27 | 107 | 4 | MM15908 | |
| Pathway | BIOCARTA_AKAP13_PATHWAY | 6.71e-05 | 11 | 107 | 3 | M17668 | |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 6.71e-05 | 11 | 107 | 3 | MM15008 | |
| Pathway | WP_GPCRS_OTHER | 7.41e-05 | 93 | 107 | 6 | M39629 | |
| Pathway | WP_GPCRS_OTHER | 8.85e-05 | 96 | 107 | 6 | MM15939 | |
| Pathway | REACTOME_SEROTONIN_RECEPTORS | 8.90e-05 | 12 | 107 | 3 | M6034 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 9.58e-05 | 32 | 107 | 4 | MM14957 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY | 9.58e-05 | 32 | 107 | 4 | M47962 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | GABRB2 DRD4 HTR1D CYP2D6 MC4R GRM4 SLC6A4 ADORA2A MTRR CNR1 CNR2 | 1.06e-04 | 367 | 107 | 11 | M48346 |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.08e-04 | 33 | 107 | 4 | M188 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 2.10e-04 | 39 | 107 | 4 | MM15695 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 2.22e-04 | 16 | 107 | 3 | MM14680 | |
| Pathway | REACTOME_DRUG_ADME | 2.88e-04 | 119 | 107 | 6 | MM15692 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 4.10e-04 | 178 | 107 | 7 | M2890 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC7A7 SLC7A9 SLC7A1 SLC44A1 SLC5A12 SLC29A4 SLC6A14 SLC44A3 | 4.55e-04 | 238 | 107 | 8 | MM15076 |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 5.52e-04 | 50 | 107 | 4 | M47951 | |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 5.62e-04 | 5 | 107 | 2 | M27301 | |
| Pathway | REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS | 5.62e-04 | 5 | 107 | 2 | M27277 | |
| Pathway | REACTOME_DOPAMINE_RECEPTORS | 5.62e-04 | 5 | 107 | 2 | MM15007 | |
| Pathway | REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS | 5.62e-04 | 5 | 107 | 2 | MM14977 | |
| Pathway | PID_HEDGEHOG_2PATHWAY | 5.89e-04 | 22 | 107 | 3 | M211 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 5.89e-04 | 22 | 107 | 3 | MM15961 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC7A7 SLC7A9 SLC7A1 SLC44A1 SLC5A12 SLC29A4 SLC6A14 SLC44A3 | 6.13e-04 | 249 | 107 | 8 | M5988 |
| Pathway | WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY | 6.68e-04 | 92 | 107 | 5 | MM15823 | |
| Pathway | WP_NRF2_PATHWAY | 7.11e-04 | 141 | 107 | 6 | M39454 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 7.51e-04 | 197 | 107 | 7 | M12289 | |
| Pathway | WP_OXYLIPINS_PATHWAYS | 7.66e-04 | 24 | 107 | 3 | MM17249 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 8.66e-04 | 25 | 107 | 3 | MM14858 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 9.10e-04 | 57 | 107 | 4 | M39812 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 9.73e-04 | 26 | 107 | 3 | MM15190 | |
| Pathway | BIOCARTA_CB1R_PATHWAY | 1.17e-03 | 7 | 107 | 2 | MM1569 | |
| Pathway | BIOCARTA_CB1R_PATHWAY | 1.17e-03 | 7 | 107 | 2 | M22054 | |
| Pathway | WP_GPCRS_ODORANT | 1.24e-03 | 157 | 107 | 6 | MM15872 | |
| Pathway | WP_CANNABINOID_RECEPTOR_SIGNALING | 1.35e-03 | 29 | 107 | 3 | M39676 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.38e-03 | 108 | 107 | 5 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.43e-03 | 109 | 107 | 5 | MM15074 | |
| Pathway | REACTOME_LIGAND_RECEPTOR_INTERACTIONS | 1.55e-03 | 8 | 107 | 2 | M27496 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP8A2 TRPC1 SLC7A7 ABCC6 SLC7A9 SLC7A1 SLC44A1 STEAP3 SLC5A12 ABCC2 SLC29A4 SLC6A14 SLC44A3 | 1.92e-03 | 681 | 107 | 13 | MM14985 |
| Pathway | WP_GPCRS_PEPTIDE | 1.96e-03 | 70 | 107 | 4 | MM15959 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 1.97e-03 | 33 | 107 | 3 | MM15963 | |
| Pathway | WP_PURINERGIC_SIGNALING | 1.97e-03 | 33 | 107 | 3 | M39855 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 2.28e-03 | 177 | 107 | 6 | M27476 | |
| Pathway | WP_PEPTIDE_GPCRS | 2.52e-03 | 75 | 107 | 4 | M39696 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 2.96e-03 | 38 | 107 | 3 | MM14600 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 3.58e-03 | 12 | 107 | 2 | MM14847 | |
| Pathway | WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS | 3.58e-03 | 12 | 107 | 2 | M48096 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 3.58e-03 | 12 | 107 | 2 | MM15616 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP8A2 TRPC1 SLC7A7 ABCC6 SLC7A9 SLC7A1 SLC44A1 STEAP3 SLC5A12 ABCC2 SLC29A4 SLC6A14 SLC44A3 | 3.75e-03 | 736 | 107 | 13 | M27287 |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 3.88e-03 | 197 | 107 | 6 | MM14970 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | 4.21e-03 | 43 | 107 | 3 | M39706 | |
| Pathway | WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING | 4.22e-03 | 13 | 107 | 2 | M39589 | |
| Pubmed | TBXA2R NPBWR2 DRD3 DRD4 HTR1B HTR1D HTR5A S1PR2 LPAR1 BDKRB1 S1PR5 P2RY10 TACR3 CNR1 CNR2 | 5.54e-15 | 179 | 159 | 15 | 18577758 | |
| Pubmed | Lysophospholipid receptor nomenclature review: IUPHAR Review 8. | 2.28e-13 | 15 | 159 | 7 | 24602016 | |
| Pubmed | TBXA2R NPBWR2 DRD3 DRD4 HTR1B HTR1D HTR5A GPER1 BDKRB1 ADORA2A P2RY10 CNR1 CNR2 | 9.81e-12 | 200 | 159 | 13 | 18240029 | |
| Pubmed | Expression patterns of the lysophospholipid receptor genes during mouse early development. | 1.39e-11 | 13 | 159 | 6 | 18924241 | |
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | GABRB2 DRD3 DRD4 HTR1B HTR1D HTR5A MC4R SLC6A4 ADORA2A TACR1 CNR1 CNR2 | 5.34e-11 | 182 | 159 | 12 | 20468064 |
| Pubmed | 6.74e-11 | 75 | 159 | 9 | 2834384 | ||
| Pubmed | 4.64e-10 | 10 | 159 | 5 | 12401212 | ||
| Pubmed | Stable association between G alpha(q) and phospholipase C beta 1 in living cells. | 5.83e-10 | 95 | 159 | 9 | 16754659 | |
| Pubmed | 2.10e-09 | 5 | 159 | 4 | 31633020 | ||
| Pubmed | 2.10e-09 | 5 | 159 | 4 | 20505096 | ||
| Pubmed | 6.26e-09 | 6 | 159 | 4 | 33317583 | ||
| Pubmed | 9.04e-09 | 58 | 159 | 7 | 11140838 | ||
| Pubmed | LPA2 promotes neuronal differentiation and neurite formation in neocortical development. | 1.46e-08 | 7 | 159 | 4 | 35151977 | |
| Pubmed | GABRB2 NPR3 HTR1B HTR1D HTR5A GRM4 BDKRB1 SLC6A4 ADORA2A TACR1 NRG3 CNR1 | 1.57e-08 | 300 | 159 | 12 | 19086053 | |
| Pubmed | 2.90e-08 | 8 | 159 | 4 | 19860625 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 7.64e-08 | 118 | 159 | 8 | 19156168 | |
| Pubmed | 8.65e-08 | 10 | 159 | 4 | 16434032 | ||
| Pubmed | Lysophosphatidic acid induces neurite branch formation through LPA3. | 8.65e-08 | 10 | 159 | 4 | 22465231 | |
| Pubmed | Enhancement of invasion of hepatocellular carcinoma cells through lysophosphatidic acid receptor. | 9.38e-08 | 3 | 159 | 3 | 23569130 | |
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 12123830 | ||
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 19899077 | ||
| Pubmed | The major central endocannabinoid directly acts at GABA(A) receptors. | 9.38e-08 | 3 | 159 | 3 | 22025726 | |
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 11093753 | ||
| Pubmed | LPA receptor expression in the central nervous system in health and following injury. | 9.38e-08 | 3 | 159 | 3 | 20495828 | |
| Pubmed | 9.38e-08 | 3 | 159 | 3 | 19025891 | ||
| Pubmed | Age-dependent loss of sperm production in mice via impaired lysophosphatidic acid signaling. | 9.38e-08 | 3 | 159 | 3 | 18448840 | |
| Pubmed | Different gamma-glutamyl transpeptidase mRNAs are expressed in human liver and kidney. | 9.38e-08 | 3 | 159 | 3 | 2573352 | |
| Pubmed | Stimulatory actions of lysophosphatidic acid on mouse ATDC5 chondroprogenitor cells. | 1.35e-07 | 11 | 159 | 4 | 20458606 | |
| Pubmed | 1.42e-07 | 52 | 159 | 6 | 18583979 | ||
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 1.44e-07 | 128 | 159 | 8 | 19058789 | |
| Pubmed | 1.69e-07 | 28 | 159 | 5 | 19737523 | ||
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 27760754 | ||
| Pubmed | Genetic polymorphisms and personality in healthy adults: a systematic review and meta-analysis. | 3.74e-07 | 4 | 159 | 3 | 12808427 | |
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 24061591 | ||
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 28069828 | ||
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 24429286 | ||
| Pubmed | Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. | 3.74e-07 | 4 | 159 | 3 | 11087877 | |
| Pubmed | 3.74e-07 | 4 | 159 | 3 | 19081821 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ITPRIPL2 NUP85 LPAR5 RHBDF2 SZT2 KIF26A TMEM94 ARFGEF2 FGFRL1 GRID1 PTCH1 JAG2 SLC7A1 THADA SH3TC1 STEAP3 ATG9A ANKRD16 CD276 | 8.02e-07 | 1105 | 159 | 19 | 35748872 |
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 23615310 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 11003618 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 10392451 | ||
| Pubmed | Molecular mechanism of lysophosphatidic acid-induced hypertensive response. | 9.31e-07 | 5 | 159 | 3 | 30804442 | |
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 9.31e-07 | 5 | 159 | 3 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 9.31e-07 | 5 | 159 | 3 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 9.31e-07 | 5 | 159 | 3 | 11089562 | |
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 9.31e-07 | 5 | 159 | 3 | 12225953 | |
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 7775425 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 9139708 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 9.31e-07 | 5 | 159 | 3 | 9546365 | |
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 9.31e-07 | 5 | 159 | 3 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 9.31e-07 | 5 | 159 | 3 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 9.31e-07 | 5 | 159 | 3 | 24698228 | |
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 10474818 | ||
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 9.31e-07 | 5 | 159 | 3 | 18063838 | |
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 9.31e-07 | 5 | 159 | 3 | 11095909 | |
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 7641802 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 18253134 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 9627710 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 12453183 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 2891746 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 20545463 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 9.31e-07 | 5 | 159 | 3 | 12468440 | |
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 9.31e-07 | 5 | 159 | 3 | 8566783 | |
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 30591459 | ||
| Pubmed | 9.31e-07 | 5 | 159 | 3 | 11795900 | ||
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 9.31e-07 | 5 | 159 | 3 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 9.31e-07 | 5 | 159 | 3 | 19760322 | |
| Pubmed | 1.08e-06 | 40 | 159 | 5 | 21319224 | ||
| Pubmed | Association study of the serotoninergic system in migraine in the Spanish population. | 1.22e-06 | 18 | 159 | 4 | 19455600 | |
| Pubmed | 1.22e-06 | 18 | 159 | 4 | 19506906 | ||
| Pubmed | 1.57e-06 | 43 | 159 | 5 | 18510611 | ||
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 1.75e-06 | 79 | 159 | 6 | 12679517 | |
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 14634009 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 1.86e-06 | 6 | 159 | 3 | 8101000 | |
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 1.86e-06 | 6 | 159 | 3 | 8104871 | |
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 11463821 | ||
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 25326709 | ||
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 12163373 | ||
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 15755723 | ||
| Pubmed | A new phospholipid phosphatase, PRG-1, is involved in axon growth and regenerative sprouting. | 1.86e-06 | 6 | 159 | 3 | 12730698 | |
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 22242126 | ||
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 17363454 | ||
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 11443127 | ||
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 8663190 | ||
| Pubmed | 1.86e-06 | 6 | 159 | 3 | 11313151 | ||
| Pubmed | 2.37e-06 | 21 | 159 | 4 | 18270970 | ||
| Pubmed | Suicide and serotonin: study of variation at seven serotonin receptor genes in suicide completers. | 3.24e-06 | 7 | 159 | 3 | 12627464 | |
| Pubmed | [The molecular-genetic study of juvenile endogenous attack-like psychoses]. | 3.24e-06 | 7 | 159 | 3 | 18379473 | |
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 3.24e-06 | 7 | 159 | 3 | 32284594 | |
| Pubmed | 3.24e-06 | 7 | 159 | 3 | 16782887 | ||
| Pubmed | Correlates of response to Olanzapine in a North Indian Schizophrenia sample. | 3.24e-06 | 7 | 159 | 3 | 19000940 | |
| Pubmed | 3.24e-06 | 7 | 159 | 3 | 20071033 | ||
| Pubmed | 3.24e-06 | 7 | 159 | 3 | 36685533 | ||
| Interaction | TSPAN15 interactions | AGPAT3 TMEM63B S1PR2 TMC4 LPAR1 SLC22A9 SLC7A1 LPAR2 MFSD8 TACR1 TACR3 MOG | 6.15e-07 | 276 | 142 | 12 | int:TSPAN15 |
| Interaction | FAM241A interactions | 6.26e-07 | 102 | 142 | 8 | int:FAM241A | |
| Interaction | GPRC5C interactions | 6.74e-07 | 103 | 142 | 8 | int:GPRC5C | |
| Interaction | TNFRSF10C interactions | 6.74e-07 | 103 | 142 | 8 | int:TNFRSF10C | |
| Interaction | YIPF3 interactions | AGPAT3 MC4R TMEM63B TMEM63C P2RY8 SIDT2 LPAR2 MFSD8 TACR1 GPR45 | 8.16e-07 | 186 | 142 | 10 | int:YIPF3 |
| Interaction | GPR89A interactions | 2.16e-06 | 120 | 142 | 8 | int:GPR89A | |
| Interaction | MFSD8 interactions | 3.65e-06 | 59 | 142 | 6 | int:MFSD8 | |
| Interaction | GNAQ interactions | 5.20e-06 | 135 | 142 | 8 | int:GNAQ | |
| Interaction | ARL6IP5 interactions | 9.00e-06 | 192 | 142 | 9 | int:ARL6IP5 | |
| Interaction | TTYH1 interactions | LPAR3 ITPRIPL2 TMEM94 AGPAT3 TMEM63B S1PR2 SLC35F1 LPAR1 S1PR5 SLC44A1 STEAP3 | 9.38e-06 | 300 | 142 | 11 | int:TTYH1 |
| Interaction | ERMP1 interactions | 9.74e-06 | 147 | 142 | 8 | int:ERMP1 | |
| Interaction | TMEM9B interactions | 1.37e-05 | 111 | 142 | 7 | int:TMEM9B | |
| Interaction | REEP6 interactions | 1.45e-05 | 112 | 142 | 7 | int:REEP6 | |
| Interaction | KIAA2013 interactions | 1.83e-05 | 116 | 142 | 7 | int:KIAA2013 | |
| Interaction | SIGMAR1 interactions | 1.93e-05 | 117 | 142 | 7 | int:SIGMAR1 | |
| Interaction | KDELR3 interactions | 2.93e-05 | 51 | 142 | 5 | int:KDELR3 | |
| Interaction | PTDSS2 interactions | 3.96e-05 | 89 | 142 | 6 | int:PTDSS2 | |
| Interaction | SCAMP2 interactions | 4.21e-05 | 132 | 142 | 7 | int:SCAMP2 | |
| Interaction | FAM20B interactions | 5.49e-05 | 58 | 142 | 5 | int:FAM20B | |
| Interaction | ABCB8 interactions | 6.47e-05 | 60 | 142 | 5 | int:ABCB8 | |
| Interaction | CD53 interactions | 7.20e-05 | 99 | 142 | 6 | int:CD53 | |
| Interaction | MT-CO1 interactions | 7.58e-05 | 62 | 142 | 5 | int:MT-CO1 | |
| Interaction | SMO interactions | 8.19e-05 | 63 | 142 | 5 | int:SMO | |
| Interaction | SERINC1 interactions | 8.19e-05 | 63 | 142 | 5 | int:SERINC1 | |
| Interaction | SMCO4 interactions | 8.83e-05 | 64 | 142 | 5 | int:SMCO4 | |
| Interaction | TMEM11 interactions | 9.99e-05 | 105 | 142 | 6 | int:TMEM11 | |
| Interaction | SACM1L interactions | 1.03e-04 | 152 | 142 | 7 | int:SACM1L | |
| Interaction | YIPF4 interactions | 1.18e-04 | 68 | 142 | 5 | int:YIPF4 | |
| Interaction | SLC19A2 interactions | 1.27e-04 | 69 | 142 | 5 | int:SLC19A2 | |
| Interaction | GGT2P interactions | 1.47e-04 | 3 | 142 | 2 | int:GGT2P | |
| Interaction | SLC39A4 interactions | 1.59e-04 | 163 | 142 | 7 | int:SLC39A4 | |
| Interaction | SLC35B4 interactions | 1.77e-04 | 40 | 142 | 4 | int:SLC35B4 | |
| Interaction | YIPF6 interactions | 1.81e-04 | 117 | 142 | 6 | int:YIPF6 | |
| Interaction | SYNGR2 interactions | 1.88e-04 | 75 | 142 | 5 | int:SYNGR2 | |
| Interaction | TTYH3 interactions | 1.88e-04 | 75 | 142 | 5 | int:TTYH3 | |
| Interaction | PTGIR interactions | 2.26e-04 | 78 | 142 | 5 | int:PTGIR | |
| Interaction | ZDHHC12 interactions | 2.38e-04 | 123 | 142 | 6 | int:ZDHHC12 | |
| Interaction | CD47 interactions | 2.40e-04 | 79 | 142 | 5 | int:CD47 | |
| Interaction | SHH interactions | 2.59e-04 | 18 | 142 | 3 | int:SHH | |
| Interaction | GPR21 interactions | 2.70e-04 | 81 | 142 | 5 | int:GPR21 | |
| Interaction | HTR1D interactions | 2.93e-04 | 4 | 142 | 2 | int:HTR1D | |
| Interaction | TAC4 interactions | 2.93e-04 | 4 | 142 | 2 | int:TAC4 | |
| Interaction | MFSD5 interactions | 3.57e-04 | 86 | 142 | 5 | int:MFSD5 | |
| Interaction | GALNT15 interactions | 3.58e-04 | 20 | 142 | 3 | int:GALNT15 | |
| Interaction | SELENOT interactions | 3.91e-04 | 49 | 142 | 4 | int:SELENOT | |
| Interaction | SLC4A2 interactions | 3.93e-04 | 135 | 142 | 6 | int:SLC4A2 | |
| Interaction | CMTM6 interactions | 4.18e-04 | 89 | 142 | 5 | int:CMTM6 | |
| Interaction | MSMO1 interactions | 4.40e-04 | 90 | 142 | 5 | int:MSMO1 | |
| Interaction | FAM241B interactions | 4.40e-04 | 90 | 142 | 5 | int:FAM241B | |
| Interaction | TMEM179B interactions | 4.63e-04 | 91 | 142 | 5 | int:TMEM179B | |
| Interaction | NHERF4 interactions | 4.78e-04 | 22 | 142 | 3 | int:NHERF4 | |
| Interaction | STARD3NL interactions | 4.92e-04 | 52 | 142 | 4 | int:STARD3NL | |
| Interaction | LYPD3 interactions | 4.95e-04 | 141 | 142 | 6 | int:LYPD3 | |
| Interaction | CCR2 interactions | 5.29e-04 | 53 | 142 | 4 | int:CCR2 | |
| Interaction | DGLUCY interactions | 5.47e-04 | 23 | 142 | 3 | int:DGLUCY | |
| Cytoband | 17q25.1 | 1.87e-04 | 81 | 159 | 4 | 17q25.1 | |
| GeneFamily | Solute carriers | SLC22A23 SLC35F1 SLC7A7 SLC7A9 SLC6A4 SLC22A9 SLC7A1 SLC44A1 SLC41A3 SLC22A14 SLC16A14 SLC49A3 SLC5A12 SLC51A SLC29A4 SLC6A14 SLC44A3 SLC23A3 SLC22A31 | 1.22e-11 | 395 | 119 | 19 | 752 |
| GeneFamily | Lysophosphatidic acid receptors | 2.65e-08 | 6 | 119 | 4 | 205 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 1.25e-05 | 78 | 119 | 6 | 262 | |
| GeneFamily | Cannabinoid receptors | 4.30e-05 | 2 | 119 | 2 | 202 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 7.58e-05 | 13 | 119 | 3 | 170 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 7.58e-05 | 13 | 119 | 3 | 564 | |
| GeneFamily | Tachykinin receptors | 1.28e-04 | 3 | 119 | 2 | 258 | |
| GeneFamily | Dopamine receptors | 4.24e-04 | 5 | 119 | 2 | 181 | |
| GeneFamily | Sphingosine 1-phosphate receptors|CD molecules | 4.24e-04 | 5 | 119 | 2 | 206 | |
| GeneFamily | Olfactory receptors, family 11 | 4.47e-04 | 23 | 119 | 3 | 159 | |
| GeneFamily | Purinergic receptors P2Y | 1.87e-03 | 10 | 119 | 2 | 213 | |
| GeneFamily | ATP binding cassette subfamily C | 3.20e-03 | 13 | 119 | 2 | 807 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 7.04e-03 | 115 | 119 | 4 | 769 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | GPR4 NPR3 GPER1 ADGRL4 ADGRG6 JAG2 ADORA2A TMTC1 CLDN5 TACR1 | 7.08e-10 | 173 | 159 | 10 | ec88e871b49331fca59bc610a8ae58e2d5e76bc1 |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | GPR4 NPR3 GPER1 ADGRL4 ADGRG6 JAG2 ADORA2A TMTC1 CLDN5 TACR1 | 7.08e-10 | 173 | 159 | 10 | 22200fe74e33e2beae0eed289ca8476bbc0b1b2d |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.15e-08 | 198 | 159 | 9 | 6fd984da5d2c419aeb34c8cbd8a00440e2f820a5 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.53e-08 | 200 | 159 | 9 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.01e-07 | 172 | 159 | 8 | de9b11ab109d04937186c09772cec9105a935f95 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.36e-07 | 184 | 159 | 8 | 667846c422cfa27e949a24844a305df859cb6760 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.36e-07 | 184 | 159 | 8 | a6f8b42982ec0cf44b950a2cd9715d068eec4ecb | |
| ToppCell | COVID-19-Myeloid-DC1|Myeloid / Condition, Lineage and Cell class | 4.47e-07 | 191 | 159 | 8 | 4be3c6287965fe3a2f109d26f68bdc2fa393f99b | |
| ToppCell | (6)_Endothelial-B_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.03e-07 | 194 | 159 | 8 | 0cf4e67d4024652794b5bfdd4a71a7d98900b4c8 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.09e-07 | 199 | 159 | 8 | fff88d2bba262583bb726900ae01e44954b72eb9 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.09e-07 | 199 | 159 | 8 | 15db14eff63d5edeced0738542d5fb739225511b | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-07 | 200 | 159 | 8 | 7547d6339f9380d031cfd2cce21ac9a12491e085 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.00e-06 | 173 | 159 | 7 | b6aed736d8480e3a6a5718aabd2fb79b1b75fa48 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-06 | 174 | 159 | 7 | 3d4c05ea5719ca65e85d1f15198453034791087c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.49e-06 | 177 | 159 | 7 | b07e6139618d888a9fd7cf43cad0d86a3f63e09e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.49e-06 | 177 | 159 | 7 | 6376ec12322c04d5d37ec2fdc376700464cbc7fb | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.49e-06 | 177 | 159 | 7 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-06 | 178 | 159 | 7 | 804ac3725c1f88e2212172bfb9aa01d97a735621 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-06 | 178 | 159 | 7 | 363e8b23b3834692a8a79e5fdc7b43bd3a4dab5e | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-06 | 178 | 159 | 7 | ad6dc4a375664c919bd48c35c48a561fc5a7de8c | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-06 | 178 | 159 | 7 | e1e96a0e3ff718ebf676a982bc63e8ced6984059 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.90e-06 | 180 | 159 | 7 | 40a12eb852373ae3d7c8d9bca376b0ae99f724b3 | |
| ToppCell | PCW_07-8.5-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.35e-06 | 183 | 159 | 7 | e0854864d377e158a4793088d1cb6b3dbf2c805d | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cdkn2b_(Cdkn2b)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.42e-06 | 119 | 159 | 6 | a3807e738d7ca8cf80aa4bd35e3ee4357b1dc00f | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cdkn2b_(Cdkn2b)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.42e-06 | 119 | 159 | 6 | 8a3f0a3ed9f80d7b061162e9fa519bb09804a86c | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cdkn2b_(Cdkn2b)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.42e-06 | 119 | 159 | 6 | 938da0fe90372709048bf4e5503cc1cbf8376b17 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 184 | 159 | 7 | 6b0c110d8930df99043c3b99cf4d873985126960 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 184 | 159 | 7 | 35928fc5f7bbf8c7b09181a2bd27e22dff42ec16 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.51e-06 | 184 | 159 | 7 | 16ed515fb673a9d6973133afcda0a3fba4a8d9dc | |
| ToppCell | Endothelial-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 4.67e-06 | 185 | 159 | 7 | dee0b7ba2f338f0979d2306aedf52ac35a36b60c | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.01e-06 | 187 | 159 | 7 | be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-06 | 189 | 159 | 7 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-06 | 189 | 159 | 7 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 5.57e-06 | 190 | 159 | 7 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.57e-06 | 190 | 159 | 7 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 5.57e-06 | 190 | 159 | 7 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.57e-06 | 190 | 159 | 7 | ec6b8e2852e1cce0217ff61243defe98b2351640 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-06 | 191 | 159 | 7 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | B_cells-Activate_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.17e-06 | 193 | 159 | 7 | b6da81920cf2e55f87ec8d4b2b5530cbf7ba2155 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.17e-06 | 193 | 159 | 7 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | severe-Myeloid-CD16_Monocytes|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.38e-06 | 194 | 159 | 7 | 1b33248b8a7cb914783bcf9e6a80481b4db7e0e8 | |
| ToppCell | Endothelial-A-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 6.38e-06 | 194 | 159 | 7 | abea887dd472c1a0d572e690bc8914c1b94712ad | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.38e-06 | 194 | 159 | 7 | 2e5b195e02dcd5e9432b9a98b22e0478e65b9ba2 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.38e-06 | 194 | 159 | 7 | b6b5b0ab506b05a005ba8a05a3c7f4c725ba9200 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-06 | 195 | 159 | 7 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.60e-06 | 195 | 159 | 7 | 3311a1bf4ed94820b45047d44fc14b14ac72e6fb | |
| ToppCell | severe-Myeloid-CD16_Monocytes|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.60e-06 | 195 | 159 | 7 | 5badcfdeed2fb7453a9c144506ca91c5475cd35f | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.82e-06 | 196 | 159 | 7 | cf7f384c1771274e766bab03ecc3dfbd13f2df60 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.82e-06 | 196 | 159 | 7 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 7.05e-06 | 197 | 159 | 7 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.05e-06 | 197 | 159 | 7 | a78111171819db746af7b162c77f9a324453f3ce | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-Treg|ICU-SEP / Disease, condition lineage and cell class | 7.05e-06 | 197 | 159 | 7 | c3ee2d522fbfe67069ddba2d1abfc4f5ca230c26 | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.36e-06 | 130 | 159 | 6 | ab141d91988a5de6d092757377a53f7de3707556 | |
| ToppCell | Cerebellum-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.36e-06 | 130 | 159 | 6 | 3d81151ee1369d819843826fc6ac197d83255e1d | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.53e-06 | 199 | 159 | 7 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | COVID-19-lung-Capillary_2|lung / Disease (COVID-19 only), tissue and cell type | 7.53e-06 | 199 | 159 | 7 | 793ce71b78a68033ef4419ed571e1dd86b40124f | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.53e-06 | 199 | 159 | 7 | d66514bdffdd96468b543ec96041e42c12472e66 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.53e-06 | 199 | 159 | 7 | d58edc5f74970bb26d844746184e4bae7c494d6b | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.53e-06 | 199 | 159 | 7 | 68412bc39639edc4045437d62548f7101b9f1989 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.53e-06 | 199 | 159 | 7 | 9735a1dc10910f02f1106b20ae5ab4c09c21305e | |
| ToppCell | LPS_IL1RA-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.53e-06 | 199 | 159 | 7 | f197ab861767ee06aa47b86c537fb3d8c2b2bc3e | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 7.78e-06 | 200 | 159 | 7 | 34b279804475ea58fbb052b96f44128c082627a9 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.78e-06 | 200 | 159 | 7 | 5b4a54cd81bc4d9f5e92798362239e1aa1b70bee | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.78e-06 | 200 | 159 | 7 | 8552cc7a439449b30b59760c3e8667217b9852b5 | |
| ToppCell | Biopsy_Control_(H.)-Endothelial|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.78e-06 | 200 | 159 | 7 | 6a9b6a4b4f204598290ae21c87ddb42ac95dfc4c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal-BMP_responsible_cell|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 7.78e-06 | 200 | 159 | 7 | 604a88633d4162337e394155c7346dbdef8b9f5a | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Artery|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 7.78e-06 | 200 | 159 | 7 | 590d1c0f86f136c7e76ea107fbb8ac5ff1164386 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.78e-06 | 200 | 159 | 7 | 45c08f1befe78553bbadcc2fcffb6138306638f3 | |
| ToppCell | Biopsy_Control_(H.)-Endothelial-Endothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 7.78e-06 | 200 | 159 | 7 | 0242d465da2dfba0da629a43e152949c5192465b | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.78e-06 | 200 | 159 | 7 | 622206c33640cb2694fe158e8dc55515bb7bd4f5 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Mesenchymal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 7.78e-06 | 200 | 159 | 7 | 5c638c80661017c85f9390f1b398ac7728c8f001 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.04e-05 | 138 | 159 | 6 | 8d70e64843f7c3be8ee4203cc126fdf1001f0df5 | |
| ToppCell | Ciliated_cells-B-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 1.60e-05 | 149 | 159 | 6 | 6399c5a2f06d79f020dece252526f1c0c110d569 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.32e-05 | 159 | 159 | 6 | 7c2f70a7cba880115ccd676fb6c5f18488a5b74f | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.40e-05 | 160 | 159 | 6 | 04714d0b9bad4c11fa193ed168e2d84a4df39e2e | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-05 | 160 | 159 | 6 | 731def6d82814ebac1a400bc7aea5f6da43ec960 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.40e-05 | 160 | 159 | 6 | cf27b4ac4d0caa6f9b068dc8ea93472470a01a4d | |
| ToppCell | C_02|World / shred on cell type and cluster | 2.85e-05 | 165 | 159 | 6 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.95e-05 | 166 | 159 | 6 | d373f1092e85eeb317a7406032b259f11e6adbe0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.95e-05 | 166 | 159 | 6 | f453a1d545d59003d98485ac31e85e6cf451817c | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.15e-05 | 168 | 159 | 6 | c7021748003e5949f7caf7b3291c5bad294948c1 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.26e-05 | 169 | 159 | 6 | 605cc2638271803cf1d972ab3fa8f13f89666376 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.26e-05 | 169 | 159 | 6 | 337be3bf485b54afad86e256cb0c4c1d0c2a9a2a | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(4)_1wkpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 3.43e-05 | 103 | 159 | 5 | 942cc6f9699f777638e59aee40a402a16fdbb2e7 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122|Adult / Lineage, Cell type, age group and donor | 3.48e-05 | 171 | 159 | 6 | bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.48e-05 | 171 | 159 | 6 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | T_cells-GNLY+GZMB+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.48e-05 | 171 | 159 | 6 | 04c811817cfec45af5f2891793106cc7ddb0300e | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.48e-05 | 171 | 159 | 6 | 3d60e7ecf25e4b781ba2387671b2aad247fb75ff | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 172 | 159 | 6 | db5a31cafce4346fe459d7f35210823fd7004439 | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 172 | 159 | 6 | 24ecfda5e43e28f190089770cd2eae5bf2ed292b | |
| ToppCell | Endothelial-A-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 3.60e-05 | 172 | 159 | 6 | a3201773a25832e92dd113fad165f1ecd37f5e91 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.72e-05 | 173 | 159 | 6 | 62ba49c1c16760a8c6cde0cc44e068f94386946a | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-05 | 173 | 159 | 6 | 63f03abca84ae021ff34ff34537838aa8a1ccd11 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 3.72e-05 | 173 | 159 | 6 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.72e-05 | 173 | 159 | 6 | b57d14e2c2368304cb903562d06ce8228f53857c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-05 | 174 | 159 | 6 | 5bde24eb588dc588efc413811379548120ec0c7f | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.84e-05 | 174 | 159 | 6 | 18ab52d8bbca0507fee220e0c4fc765fc47dda34 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-05 | 174 | 159 | 6 | 1b2a2129c08bac01fc638692313b196759a1e0d7 | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.84e-05 | 174 | 159 | 6 | f1510b0f7771936adf29ae3572feab55db31832b | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.84e-05 | 174 | 159 | 6 | 5d5d2fc60afff47f997751e8e9ca1367a22d19ec | |
| Computational | Genes in the cancer module 146. | 6.47e-08 | 102 | 81 | 9 | MODULE_146 | |
| Computational | Genes in the cancer module 27. | TNFRSF25 FLT3 NPR3 DRD3 DRD4 S1PR2 LPAR1 BDKRB1 ADORA2A P2RY10 TACR3 ADGRE1 CNR1 CNR2 | 3.48e-07 | 355 | 81 | 14 | MODULE_27 |
| Computational | Membranal receptors. | IL24 TNFRSF25 FLT3 NPR3 DRD3 LPAR1 SLC6A4 P2RY10 TACR3 ADGRE1 MUC1 CNR1 CNR2 | 1.18e-04 | 517 | 81 | 13 | MODULE_64 |
| Computational | Genes in the cancer module 289. | 3.34e-04 | 124 | 81 | 6 | MODULE_289 | |
| Drug | aganodine | 1.98e-14 | 23 | 156 | 9 | CID000176878 | |
| Drug | N-palmitoyl-L-tyrosine | 8.45e-11 | 6 | 156 | 5 | CID000389046 | |
| Drug | quinelorane | 1.32e-10 | 37 | 156 | 8 | CID000057242 | |
| Drug | Brain Pi(4,5)p2 | 2.94e-10 | 7 | 156 | 5 | CID005497157 | |
| Drug | VPC12249 | 7.80e-10 | 8 | 156 | 5 | CID005311306 | |
| Drug | N-palmitoyl-serine | 7.80e-10 | 8 | 156 | 5 | CID000085997 | |
| Drug | NAN-190 | 1.02e-09 | 47 | 156 | 8 | CID000004431 | |
| Drug | AC1L1KS5 | TBXA2R BOC GPR4 LPAR3 NPBWR2 NPR3 LPAR5 S1PR2 PKD1L3 GRM4 LPAR1 BDKRB1 ADORA2A LPAR2 TACR3 GPR45 | 1.34e-09 | 334 | 156 | 16 | CID000005631 |
| Drug | norbiotin | 1.55e-09 | 72 | 156 | 9 | CID000446903 | |
| Drug | fluoromethylene | 1.75e-09 | 9 | 156 | 5 | CID000186213 | |
| Drug | piperazine | 1.76e-09 | 73 | 156 | 9 | CID000004837 | |
| Drug | haloperidol | GABRB2 DRD3 DRD4 HTR1B HTR1D CYP2D7 CYP2D6 HTR5A GRID1 GRM4 SLC6A4 ADORA2A MTRR LPAR2 TACR3 CNR1 CNR2 | 1.94e-09 | 394 | 156 | 17 | CID000003559 |
| Drug | atropine sulfate | GABRB2 TBXA2R BOC GPI NPR3 DRD3 DRD4 HTR1B HTR1D HTR5A MC4R ADGRL4 ADORA2A ANTXR1 TACR1 TACR3 | 2.31e-09 | 347 | 156 | 16 | CID000003661 |
| Drug | thioridazine | 3.61e-09 | 79 | 156 | 9 | CID000005452 | |
| Drug | quetiapine | 5.04e-09 | 57 | 156 | 8 | CID000005002 | |
| Drug | chloride | GABRB2 BOC LPAR3 NPR3 HTR1B HTR1D HTR5A LPAR5 GRID1 PKD1L3 LPAR1 BDKRB1 GGT1 SLC6A4 ADORA2A MID1 LPAR2 TACR1 TACR3 SLC5A12 G6PD SLC29A4 GPR45 CNR1 CNR2 SLC6A14 | 8.16e-09 | 1029 | 156 | 26 | CID000000312 |
| Drug | baclofen | GABRB2 DRD3 DRD4 HTR1B HTR1D PKD1L3 GRM4 ADORA2A MTRR TACR1 CNR1 CNR2 | 8.43e-09 | 191 | 156 | 12 | CID000002284 |
| Drug | eptapirone | 1.05e-08 | 5 | 156 | 4 | CID000208928 | |
| Drug | tetralin | 1.14e-08 | 63 | 156 | 8 | CID000008404 | |
| Drug | AC1NBM3D | 1.14e-08 | 41 | 156 | 7 | CID004470173 | |
| Drug | phentolamine | GABRB2 TBXA2R DRD3 DRD4 HTR1B HTR1D HTR5A ADGRL4 ADORA2A TACR1 TACR3 HSD17B2 | 1.41e-08 | 200 | 156 | 12 | CID000005775 |
| Drug | MAMP | GABRB2 DRD3 DRD4 HTR1B HTR1D CYP2D7 CYP2D6 SLC6A4 ADORA2A MTRR TACR1 | 1.41e-08 | 160 | 156 | 11 | CID000001206 |
| Drug | AC-680 | 1.55e-08 | 93 | 156 | 9 | CID000004691 | |
| Drug | AC1MPVH8 | 1.62e-08 | 43 | 156 | 7 | CID003441849 | |
| Drug | MK-801 | GABRB2 DRD3 DRD4 HTR1B HTR1D GRID1 PTCH1 GRM4 SLC6A4 ADORA2A MTRR TACR1 CNR1 CNR2 | 1.77e-08 | 296 | 156 | 14 | CID000001207 |
| Drug | T15550 | 1.93e-08 | 26 | 156 | 6 | CID000005454 | |
| Drug | CY 208-243 | 2.70e-08 | 14 | 156 | 5 | CID000058144 | |
| Drug | risperidone | 3.46e-08 | 136 | 156 | 10 | CID000005073 | |
| Drug | difluoromethylene | 3.92e-08 | 29 | 156 | 6 | CID006432238 | |
| Drug | PD173956 | 4.02e-08 | 15 | 156 | 5 | CID005330524 | |
| Drug | cimetidine | BOC CYP2D7 CYP2D6 ATP8A2 LGI4 ABCC6 SLC22A9 SLC16A14 SLC5A12 ABCC2 SLC29A4 | 4.52e-08 | 179 | 156 | 11 | CID000002756 |
| Drug | sertindole | 4.83e-08 | 50 | 156 | 7 | CID000060149 | |
| Drug | aripiprazole | 5.15e-08 | 76 | 156 | 8 | CID000060795 | |
| Drug | fluoxetine | GABRB2 DRD3 DRD4 HTR1B HTR1D CYP2D7 CYP2D6 HTR5A MC4R SLC6A4 CLDN5 TACR1 | 5.21e-08 | 225 | 156 | 12 | CID000003386 |
| Drug | mesulergine | 6.00e-08 | 31 | 156 | 6 | CID000068848 | |
| Drug | methylphenidate | 6.79e-08 | 110 | 156 | 9 | CID000004158 | |
| Drug | N,N-dipropyl-5,6-ADTN | 7.30e-08 | 7 | 156 | 4 | CID000122167 | |
| Drug | UH 242 | 7.30e-08 | 7 | 156 | 4 | CID000125884 | |
| Drug | clomipramine | 7.74e-08 | 80 | 156 | 8 | CID000002801 | |
| Drug | CGS 12066B | 1.08e-07 | 34 | 156 | 6 | CID000002689 | |
| Drug | nM-1 | TBXA2R HTR1B HTR1D S1PR2 BDKRB1 ADORA2A TACR1 TACR3 CNR1 CNR2 | 1.20e-07 | 155 | 156 | 10 | CID000445754 |
| Drug | NSC186061 | 1.25e-07 | 118 | 156 | 9 | CID000004163 | |
| Drug | N-methyl-DL-aspartic acid | GABRB2 BOC NPR3 DRD3 DRD4 HTR1B HTR1D TRPC1 GRID1 PTCH1 PKD1L3 GRM4 ADORA2A MTRR TACR1 TACR3 NRG3 CNR1 CNR2 | 1.26e-07 | 655 | 156 | 19 | CID000004376 |
| Drug | GTP[S] | GPR4 LPAR3 NPR3 DRD3 DRD4 HTR1B HTR1D TRPC1 ARFGEF1 PKD1L3 GRM4 BDKRB1 ADORA2A MLC1 TACR1 GPR45 CNR1 CNR2 | 1.35e-07 | 591 | 156 | 18 | CID000001764 |
| Drug | DP-8OH-3CA | 1.45e-07 | 8 | 156 | 4 | CID000086131 | |
| Drug | 5-methoxy-1-methyl-2-(n-propylamino)tetralin | 1.45e-07 | 8 | 156 | 4 | CID000122334 | |
| Drug | UH232 | 1.45e-07 | 8 | 156 | 4 | CID005311190 | |
| Drug | BW 737C | 1.45e-07 | 8 | 156 | 4 | CID000132241 | |
| Drug | mianserin | 1.50e-07 | 87 | 156 | 8 | CID000004184 | |
| Drug | lysosphingomyelin | 1.61e-07 | 160 | 156 | 10 | CID000005263 | |
| Drug | lysophosphatidylglycerol | 1.83e-07 | 37 | 156 | 6 | CID000447308 | |
| Drug | AC1N65YL | 2.02e-07 | 20 | 156 | 5 | CID004229818 | |
| Drug | acetylcholine | TBXA2R LPAR3 DRD3 DRD4 HTR1B HTR1D SLC6A4 ADORA2A SLC44A1 LPAR2 TACR1 TACR3 CNR1 CNR2 | 2.06e-07 | 361 | 156 | 14 | CID000000187 |
| Drug | AC1Q3ZOL | GABRB2 BOC DRD3 DRD4 HTR1B HTR1D PTCH1 GRM4 ADORA2A MTRR CNR1 CNR2 | 2.30e-07 | 258 | 156 | 12 | CID000002376 |
| Drug | CQ 32-084 | 2.60e-07 | 9 | 156 | 4 | CID000068847 | |
| Drug | 11-OH-NPa | 2.60e-07 | 9 | 156 | 4 | CID000127708 | |
| Drug | CTK4D3724 | 2.60e-07 | 9 | 156 | 4 | CID000128010 | |
| Drug | AC1OCEMN | 2.60e-07 | 9 | 156 | 4 | CID006917765 | |
| Drug | U91356A | 2.60e-07 | 9 | 156 | 4 | CID000132955 | |
| Drug | olanzapine | 2.68e-07 | 129 | 156 | 9 | CID000004585 | |
| Drug | tetradotoxin | GABRB2 BOC NPR3 DRD3 DRD4 HTR1B HTR1D HTR5A PTCH1 GRM4 ADORA2A TACR1 TACR3 CNR1 CNR2 | 2.73e-07 | 428 | 156 | 15 | CID000020382 |
| Drug | fluphenazine | 2.74e-07 | 94 | 156 | 8 | CID000003372 | |
| Drug | ketanserin | 3.06e-07 | 131 | 156 | 9 | CID000003822 | |
| Drug | 5,7-dihydroxytryptamine | 3.09e-07 | 65 | 156 | 7 | CID000035781 | |
| Drug | N-propylpiperidine | 3.16e-07 | 3 | 156 | 3 | CID000021644 | |
| Drug | 2-aminotetralin | 3.39e-07 | 22 | 156 | 5 | CID000018066 | |
| Drug | 5-OH-DPAT | 4.31e-07 | 10 | 156 | 4 | CID000172267 | |
| Drug | 2-(di-n-propylamino)tetralin | 4.31e-07 | 10 | 156 | 4 | CID000090285 | |
| Drug | U-86170F | 4.31e-07 | 10 | 156 | 4 | CID000131559 | |
| Drug | SDZ 208-912 | 4.31e-07 | 10 | 156 | 4 | CID000058145 | |
| Drug | LY320135 | 4.31e-07 | 23 | 156 | 5 | CID005311257 | |
| Drug | GBR 12909 | 4.68e-07 | 69 | 156 | 7 | CID000003455 | |
| Drug | dopamine | GABRB2 NPR3 DRD3 DRD4 HTR1B HTR1D CYP2D7 CYP2D6 HTR5A MC4R GRM4 SLC6A4 ADORA2A LINGO1 TACR1 TACR3 SLC29A4 CNR1 CNR2 | 4.78e-07 | 715 | 156 | 19 | CID000000681 |
| Drug | ondansetron | 5.35e-07 | 44 | 156 | 6 | CID000004595 | |
| Drug | amitriptyline | 5.38e-07 | 140 | 156 | 9 | CID000002160 | |
| Drug | Kytril | 6.14e-07 | 45 | 156 | 6 | CID000003510 | |
| Drug | N-n-propylnorapomorphine | 6.73e-07 | 25 | 156 | 5 | CID000030137 | |
| Drug | 6-Br-APB | 6.74e-07 | 11 | 156 | 4 | CID000005016 | |
| Drug | chloral | 6.91e-07 | 73 | 156 | 7 | CID000006407 | |
| Drug | nomifensine | 7.02e-07 | 46 | 156 | 6 | CID000004528 | |
| Drug | desipramine | DRD3 DRD4 HTR1B HTR1D CYP2D7 CYP2D6 HTR5A ADGRL4 SLC6A4 ADORA2A | 7.17e-07 | 188 | 156 | 10 | CID000002995 |
| Drug | Aripiprazole | 8.00e-07 | 47 | 156 | 6 | ctd:D000068180 | |
| Drug | 5-MeODMT | 8.00e-07 | 47 | 156 | 6 | CID000001832 | |
| Drug | gamma-aminobutyric acid | GABRB2 GPI DRD3 DRD4 HTR1B HTR1D PTCH1 PKD1L3 GRM4 SLC6A4 ADORA2A TACR1 G6PD CNR1 CNR2 | 9.87e-07 | 474 | 156 | 15 | CID000000119 |
| Drug | methiothepin | 9.97e-07 | 77 | 156 | 7 | CID000004106 | |
| Drug | iodosulpride | 1.01e-06 | 12 | 156 | 4 | CID000122245 | |
| Drug | Uh 232 | 1.01e-06 | 12 | 156 | 4 | CID000123696 | |
| Drug | N,N-dipropyldopamine | 1.01e-06 | 12 | 156 | 4 | CID000003106 | |
| Drug | ocaperidone | 1.01e-06 | 12 | 156 | 4 | CID000071351 | |
| Drug | NSC169490 | 1.01e-06 | 27 | 156 | 5 | CID004210613 | |
| Drug | WAY-100635 | 1.03e-06 | 49 | 156 | 6 | CID000005684 | |
| Drug | zotepine | 1.03e-06 | 49 | 156 | 6 | CID000005736 | |
| Drug | AC1L1DXE | GPI HTR1B HTR1D ATP8A2 MC4R PKD1L3 BDKRB1 SLC6A4 TACR1 TACR3 CNR1 CNR2 | 1.10e-06 | 299 | 156 | 12 | CID000002548 |
| Drug | ink 1 | 1.26e-06 | 4 | 156 | 3 | CID000476801 | |
| Drug | 4,4'-difluorobenzophenone | 1.26e-06 | 4 | 156 | 3 | CID000009582 | |
| Drug | Tyr-D-Ala-Gly-N-methyl-Phe-Gly-ol | 1.29e-06 | 80 | 156 | 7 | CID004488326 | |
| Drug | sumatriptan | 1.29e-06 | 80 | 156 | 7 | CID000005358 | |
| Drug | M100907 | 1.31e-06 | 51 | 156 | 6 | CID000060858 | |
| Drug | SCH 23390 | 1.38e-06 | 116 | 156 | 8 | CID000005018 | |
| Drug | serotonin | TBXA2R NPR3 DRD3 DRD4 HTR1B HTR1D CYP2D7 CYP2D6 HTR5A MC4R SLC6A4 TACR1 TACR3 SLC29A4 CNR1 SLC6A14 | 1.40e-06 | 554 | 156 | 16 | CID000005202 |
| Disease | Cannabis use | 9.81e-09 | 6 | 151 | 4 | C3160814 | |
| Disease | Schizophrenia | GABRB2 DRD3 DRD4 CYP2D6 HTR5A GRID1 GRM4 LPAR1 JAG2 SLC6A4 ADORA2A MLC1 GPR153 CLDN5 TACR3 NRG3 MOG CNR1 CNR2 SLC23A3 | 2.80e-08 | 883 | 151 | 20 | C0036341 |
| Disease | Depressive disorder | DRD3 DRD4 HTR1B HTR1D CYP2D6 MC4R GRID1 SLC6A4 ADORA2A TACR1 CNR1 CNR2 | 3.47e-08 | 289 | 151 | 12 | C0011581 |
| Disease | Alcohol abuse | 5.37e-08 | 67 | 151 | 7 | C0085762 | |
| Disease | Amphetamine-Related Disorders | 1.19e-07 | 75 | 151 | 7 | C0236733 | |
| Disease | Amphetamine Abuse | 1.19e-07 | 75 | 151 | 7 | C0236807 | |
| Disease | Amphetamine Addiction | 1.19e-07 | 75 | 151 | 7 | C0236804 | |
| Disease | Alcoholic Intoxication, Chronic | GABRB2 DRD3 DRD4 HTR1B GGT1 SLC6A4 TACR1 TACR3 MOG CNR1 CNR2 | 1.48e-07 | 268 | 151 | 11 | C0001973 |
| Disease | Bipolar Disorder | GABRB2 DRD3 DRD4 HTR1B HTR5A GRID1 GRM4 SLC6A4 MLC1 TACR1 NRG3 G6PD CNR1 CNR2 | 1.81e-07 | 477 | 151 | 14 | C0005586 |
| Disease | Mood Disorders | 2.24e-07 | 168 | 151 | 9 | C0525045 | |
| Disease | Mental Depression | 8.10e-07 | 254 | 151 | 10 | C0011570 | |
| Disease | Colorectal Carcinoma | BOC NPBWR2 HTR5A OTOP2 ARFGEF1 GRID1 LPAR1 ABCC6 HPS3 GJD4 SLC22A9 SH3TC1 MTRR LGR6 ABCC2 | 3.47e-06 | 702 | 151 | 15 | C0009402 |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 4.53e-06 | 7 | 151 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 7.22e-06 | 8 | 151 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | generalized anxiety disorder (implicated_via_orthology) | 7.22e-06 | 8 | 151 | 3 | DOID:14320 (implicated_via_orthology) | |
| Disease | Unipolar Depression | 8.03e-06 | 259 | 151 | 9 | C0041696 | |
| Disease | Marijuana Abuse | 1.63e-05 | 30 | 151 | 4 | C0024809 | |
| Disease | Seizures, Focal | 1.63e-05 | 104 | 151 | 6 | C0751495 | |
| Disease | Tonic - clonic seizures | 1.63e-05 | 104 | 151 | 6 | C0494475 | |
| Disease | Primaquine response | 2.60e-05 | 2 | 151 | 2 | cv:CN322745 | |
| Disease | congenital nonspherocytic hemolytic anemia (implicated_via_orthology) | 2.60e-05 | 2 | 151 | 2 | DOID:2861 (implicated_via_orthology) | |
| Disease | Allodynia | 7.32e-05 | 84 | 151 | 5 | C0458247 | |
| Disease | Mechanical Allodynia | 7.32e-05 | 84 | 151 | 5 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 7.32e-05 | 84 | 151 | 5 | C0751212 | |
| Disease | Hyperalgesia, Primary | 7.32e-05 | 84 | 151 | 5 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 7.32e-05 | 84 | 151 | 5 | C0751214 | |
| Disease | Tactile Allodynia | 7.32e-05 | 84 | 151 | 5 | C0751213 | |
| Disease | Hyperalgesia | 7.32e-05 | 84 | 151 | 5 | C0020429 | |
| Disease | Alcohol Use Disorder | 7.63e-05 | 44 | 151 | 4 | C0001956 | |
| Disease | cystine measurement | 7.78e-05 | 3 | 151 | 2 | EFO_0800134 | |
| Disease | Cocaine Dependence | 8.34e-05 | 139 | 151 | 6 | C0600427 | |
| Disease | Colorectal Neoplasms | 9.51e-05 | 277 | 151 | 8 | C0009404 | |
| Disease | attention deficit hyperactivity disorder (is_implicated_in) | 1.40e-04 | 20 | 151 | 3 | DOID:1094 (is_implicated_in) | |
| Disease | BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1 | 1.55e-04 | 4 | 151 | 2 | 605462 | |
| Disease | Basal cell carcinoma, susceptibility to, 1 | 1.55e-04 | 4 | 151 | 2 | cv:C2751544 | |
| Disease | Oculo-dento-digital syndrome | 1.55e-04 | 4 | 151 | 2 | C0812437 | |
| Disease | solanidine measurement | 1.55e-04 | 4 | 151 | 2 | EFO_0800966 | |
| Disease | conduct disorder (is_implicated_in) | 1.55e-04 | 4 | 151 | 2 | DOID:12995 (is_implicated_in) | |
| Disease | Hypotension | 1.59e-04 | 53 | 151 | 4 | C0020649 | |
| Disease | Generalized seizures | 1.75e-04 | 101 | 151 | 5 | C0234533 | |
| Disease | Clonic Seizures | 1.75e-04 | 101 | 151 | 5 | C0234535 | |
| Disease | Convulsive Seizures | 1.75e-04 | 101 | 151 | 5 | C0751494 | |
| Disease | Seizures, Sensory | 1.75e-04 | 101 | 151 | 5 | C0751496 | |
| Disease | Non-epileptic convulsion | 1.75e-04 | 101 | 151 | 5 | C0751056 | |
| Disease | Atonic Absence Seizures | 1.75e-04 | 101 | 151 | 5 | C0751123 | |
| Disease | Complex partial seizures | 1.75e-04 | 101 | 151 | 5 | C0149958 | |
| Disease | Single Seizure | 1.75e-04 | 101 | 151 | 5 | C0751110 | |
| Disease | Nonepileptic Seizures | 1.75e-04 | 101 | 151 | 5 | C3495874 | |
| Disease | Visual seizure | 1.75e-04 | 101 | 151 | 5 | C0270824 | |
| Disease | Epileptic drop attack | 1.75e-04 | 101 | 151 | 5 | C0270846 | |
| Disease | Vertiginous seizure | 1.75e-04 | 101 | 151 | 5 | C0422855 | |
| Disease | Gustatory seizure | 1.75e-04 | 101 | 151 | 5 | C0422854 | |
| Disease | Seizures, Somatosensory | 1.75e-04 | 101 | 151 | 5 | C0422850 | |
| Disease | Olfactory seizure | 1.75e-04 | 101 | 151 | 5 | C0422853 | |
| Disease | Seizures, Auditory | 1.75e-04 | 101 | 151 | 5 | C0422852 | |
| Disease | Generalized Absence Seizures | 1.75e-04 | 101 | 151 | 5 | C4505436 | |
| Disease | Jacksonian Seizure | 1.75e-04 | 101 | 151 | 5 | C0022333 | |
| Disease | Epileptic Seizures | 1.75e-04 | 101 | 151 | 5 | C4317109 | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 1.83e-04 | 55 | 151 | 4 | DOID:9952 (is_implicated_in) | |
| Disease | Absence Seizures | 1.84e-04 | 102 | 151 | 5 | C4316903 | |
| Disease | Convulsions | 1.84e-04 | 102 | 151 | 5 | C4048158 | |
| Disease | Tonic Seizures | 1.84e-04 | 102 | 151 | 5 | C0270844 | |
| Disease | Attention Deficit Disorder | 1.88e-04 | 22 | 151 | 3 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 1.88e-04 | 22 | 151 | 3 | C1321905 | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.88e-04 | 22 | 151 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | Myoclonic Seizures | 2.01e-04 | 104 | 151 | 5 | C4317123 | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 2.16e-04 | 23 | 151 | 3 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 2.16e-04 | 23 | 151 | 3 | C0393682 | |
| Disease | Uncinate Epilepsy | 2.16e-04 | 23 | 151 | 3 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 2.16e-04 | 23 | 151 | 3 | C0014556 | |
| Disease | Etat Marbre | 2.16e-04 | 23 | 151 | 3 | C0266487 | |
| Disease | Withdrawal Symptoms | 2.26e-04 | 58 | 151 | 4 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 2.26e-04 | 58 | 151 | 4 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 2.26e-04 | 58 | 151 | 4 | C0038587 | |
| Disease | Attention deficit hyperactivity disorder | 2.46e-04 | 24 | 151 | 3 | C1263846 | |
| Disease | ICAM-1 measurement | 2.46e-04 | 24 | 151 | 3 | EFO_0004520 | |
| Disease | heart disease (is_implicated_in) | 2.58e-04 | 5 | 151 | 2 | DOID:114 (is_implicated_in) | |
| Disease | congenital nonspherocytic hemolytic anemia (is_implicated_in) | 2.58e-04 | 5 | 151 | 2 | DOID:2861 (is_implicated_in) | |
| Disease | Basal Cell Nevus Syndrome | 2.58e-04 | 5 | 151 | 2 | C0004779 | |
| Disease | Major Depressive Disorder | 2.66e-04 | 243 | 151 | 7 | C1269683 | |
| Disease | Cocaine-Related Disorders | 3.47e-04 | 117 | 151 | 5 | C0236736 | |
| Disease | occipital lobe volume measurement | 3.85e-04 | 6 | 151 | 2 | EFO_0010145 | |
| Disease | cardiovascular measurement | 3.85e-04 | 6 | 151 | 2 | EFO_0004298 | |
| Disease | Obsessive-Compulsive Disorder | 3.85e-04 | 6 | 151 | 2 | C0028768 | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 3.92e-04 | 28 | 151 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | IL24 BOC GPI MICAL1 CYP2D6 GPER1 ARFGEF2 SLC7A7 LPAR1 JAG2 SLC22A9 UTP20 LGR6 GPR45 CNR2 | 4.24e-04 | 1074 | 151 | 15 | C0006142 |
| Disease | Movement Disorders | 4.35e-04 | 29 | 151 | 3 | C0026650 | |
| Disease | Cocaine Abuse | 5.06e-04 | 127 | 151 | 5 | C0009171 | |
| Disease | obsessive-compulsive symptom measurement | 5.32e-04 | 31 | 151 | 3 | EFO_0007802 | |
| Disease | Dysphoric mood | 5.37e-04 | 7 | 151 | 2 | C0233477 | |
| Disease | plasma betaine measurement | 7.00e-04 | 34 | 151 | 3 | EFO_0007787 | |
| Disease | lung volume | 7.14e-04 | 8 | 151 | 2 | EFO_0600046 | |
| Disease | Tremor, Neonatal | 9.15e-04 | 9 | 151 | 2 | C0235843 | |
| Disease | Tremor, Perioral | 9.15e-04 | 9 | 151 | 2 | C0235078 | |
| Disease | Nerve Tremors | 9.15e-04 | 9 | 151 | 2 | C0235083 | |
| Disease | Tremor, Limb | 9.15e-04 | 9 | 151 | 2 | C0235081 | |
| Disease | Tremor, Muscle | 9.15e-04 | 9 | 151 | 2 | C0235082 | |
| Disease | Senile Tremor | 9.15e-04 | 9 | 151 | 2 | C0149840 | |
| Disease | Pill Rolling Tremor | 9.15e-04 | 9 | 151 | 2 | C0751564 | |
| Disease | Tremor, Semirhythmic | 9.15e-04 | 9 | 151 | 2 | C0751565 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IWSFIGPACLIILVN | 571 | Q9HBW9 | |
| WICLACVRLGITFVP | 126 | Q6P461 | |
| LWLLFVVVPFVILQC | 61 | Q5JX71 | |
| LILTLVVAFLVCWAP | 251 | P46663 | |
| LGIILGAFIVCWLPF | 316 | P28222 | |
| CVGSLWIPLNRVIAI | 2976 | Q96N23 | |
| LILQYLLTVCPGAWK | 151 | Q6P6B7 | |
| IGFQWLSLATLVLIC | 11 | Q9H6X2 | |
| IAVLAILGNVLVCWA | 16 | P29274 | |
| PIELLVCFSALVRWG | 681 | Q8N7X0 | |
| VITSILCNPALLGEW | 296 | Q8NHS2 | |
| ILKFCIIGWGLPALV | 971 | Q86SQ4 | |
| GWFPILFELSCIINR | 1381 | Q9Y6D6 | |
| LISLQLLGICVWFVV | 706 | Q14833 | |
| VRGWFPILFELSCII | 1326 | Q9Y6D5 | |
| PVLNVTWLCNGELVT | 146 | P20036 | |
| LWFCLTGALEVQVPE | 21 | Q5ZPR3 | |
| FWLGLFLVPTACLIE | 1071 | Q9NTI2 | |
| VLTFSPCVLLGWALL | 6 | P17342 | |
| TLGLVLAVLLICWFP | 246 | P34972 | |
| LWIPLLLVAGCVSCF | 176 | Q8NI28 | |
| FGPIWNRDNIACVIL | 221 | P11413 | |
| PRWAFSLVCGIIVLT | 481 | Q8NHS3 | |
| VSIPGNLFSLWVLCR | 36 | Q86VZ1 | |
| NRQQTWLCVVPLFIG | 61 | P56975 | |
| VLVIVGLCLWLPSAS | 16 | A6NGU5 | |
| LILRNPIAIWVSCGE | 1531 | M0R2J8 | |
| CGFLWFLIPIVLISQ | 166 | Q8NH07 | |
| IQILFTVWLPFCGPN | 156 | Q96R67 | |
| CIYIWGVVLGIIIPV | 156 | Q96P67 | |
| LCLGVWALILVFAVP | 141 | Q9H1C0 | |
| AFVVCWTPGQVVLLL | 246 | Q9HBW0 | |
| LFITPLAAISGWLCL | 146 | Q9P0N8 | |
| LAVWAIVLLSVLCNG | 566 | Q9HBX8 | |
| GLLVPVLCGAFSVLW | 1081 | Q9Y219 | |
| LGIIPCAISWLFKLI | 566 | Q2KJY2 | |
| GWLALLVASVLQPNI | 491 | Q9UBK8 | |
| VPGWGIALLVLVCVL | 1156 | P15941 | |
| VIVLGAFIICWTPGL | 261 | Q92633 | |
| AFIICWTPGLVLLLL | 266 | Q92633 | |
| RFWLIQGVCVLLPSA | 76 | Q96KN9 | |
| AVLLFVPCVGKTVWL | 6 | Q6DN72 | |
| GGVPTVLCLNIALWV | 36 | Q9P1W3 | |
| GAVFILGTLLLWLCQ | 386 | Q8N441 | |
| WNLCEILFIEVAPAG | 146 | Q9BW27 | |
| LWLLFAVVPFVILQC | 61 | Q5JX69 | |
| SVAQALLLPVFLWAC | 286 | Q6NV75 | |
| AAVVLLFAACWGPIQ | 266 | Q969F8 | |
| LFAACWGPIQLFLVL | 271 | Q969F8 | |
| GAFVVCWTPGLVVLL | 246 | Q9UBY5 | |
| PQSLGIVPCAISWLF | 486 | Q9ULI4 | |
| ISCWQPFLGLAVVLI | 6 | Q7L985 | |
| ACWQPILLLVLGSVL | 21 | Q96FE5 | |
| LLLGLVGDCLVEPFW | 386 | Q8TDZ2 | |
| GIWSFPLIIAAVCAQ | 11 | P47870 | |
| APVLLALLGIWYINC | 316 | P06744 | |
| CFEQTVLVWIPLGYL | 26 | Q92887 | |
| ASLCVWLGVTVLVLP | 166 | P48146 | |
| RVLPVVVGAFLLCWT | 346 | P21917 | |
| IIAVSWVLSFCIAGP | 151 | Q9Y5Y3 | |
| FVIGVGLPTNCLALW | 26 | P46093 | |
| CWKITLFVIVPVLGP | 206 | Q16653 | |
| PVLGPLVALIICYNW | 216 | Q16653 | |
| LIWGLPFCINIVKSL | 196 | P35410 | |
| SLWAVIVNICLPFGI | 531 | Q7RTS6 | |
| TVVSVLCCFGLWIPR | 96 | Q86UW1 | |
| LQVLVDAPGNISCLW | 91 | P36888 | |
| VLIIVTFIPFCLWRA | 866 | Q9BWV1 | |
| CLEPTNVVAWTLLGL | 731 | Q5T0N1 | |
| LQLAWTPVVVLNGLA | 71 | P10635 | |
| LWIGIANFLLCPLIL | 291 | Q7Z3C6 | |
| LSNTEAVGPCLIIWA | 56 | P82251 | |
| VNQVVAAPILCLFWL | 681 | Q5T3F8 | |
| VVLPCLGFTLLLWSQ | 31 | Q13007 | |
| IICWLPFFVVSLVLP | 311 | P28221 | |
| LCWIPFFLTELISPL | 296 | P47898 | |
| VIAVLPLLGWNCEKL | 246 | P21554 | |
| TLTILIGVFVVCWAP | 246 | P32245 | |
| TVISGCIILQLYPWK | 186 | Q9NWL6 | |
| WACIAAAIPVVGVLI | 566 | Q9ULK0 | |
| TVWVLPLIIVCLFAF | 566 | Q8WWI5 | |
| SLVILGLLFVCGVLW | 246 | Q8N4M1 | |
| ICPLSVLSNWIDQFG | 481 | Q14527 | |
| PCFNGRVVSWLVLVE | 71 | P54792 | |
| AVCLLILSPFWGLIL | 46 | P37059 | |
| QAIIWCLLLLFLPEG | 446 | Q9Y267 | |
| LASASWVPCIVLGLV | 21 | A6NKX4 | |
| TIVLGVFIVCWLPAF | 236 | O95136 | |
| VFIVCWLPAFSILLL | 241 | O95136 | |
| VLLAFVACWGPLFLL | 256 | Q9H228 | |
| VACWGPLFLLLLLDV | 261 | Q9H228 | |
| VAIVLGAFIVCWLPF | 331 | P35462 | |
| VLVIVGLCLWLPSAS | 16 | P36268 | |
| IWIVVGTACLPFPIL | 156 | O00398 | |
| CFVGAPNELLWTVTL | 146 | P0CW18 | |
| CGFLWFLIPIVLISQ | 166 | Q8NG94 | |
| CGFLWFLIPIVLISQ | 166 | B2RN74 | |
| TLNLRVFWPLVTGLC | 6 | Q3MIP1 | |
| VFWPLVTGLCTALVC | 11 | Q3MIP1 | |
| VQLLLVLWLPFCGPN | 156 | Q8NH37 | |
| GPCLPDFWLIVRVLQ | 1911 | Q5T011 | |
| TGALQCLIWVLRFPL | 2131 | O75691 | |
| VPLLLFAVLCFWLPE | 246 | Q8N4V2 | |
| WVSPLLFILCEGNLD | 526 | Q6YHU6 | |
| LIPLLCIVCTSVVWG | 746 | Q8NBJ9 | |
| CGDPSLRAVLWQILV | 26 | Q8IUW3 | |
| FSCIPIFVPLWLSLI | 241 | Q8NFB2 | |
| AQLTPFLLNAVGWLC | 71 | Q9Y4C2 | |
| ITCLWGGLLYIIVPQ | 606 | Q9Y4C2 | |
| FWEAQLVACLPDVVL | 781 | Q969F9 | |
| VLAQPFAGRCLILSW | 236 | Q8N135 | |
| GVIADLPCISVWNVF | 371 | Q7RTX9 | |
| LLSLCFLRTAGVWVP | 26 | O95255 | |
| FGAVILLANCVAPWA | 386 | Q8IVM8 | |
| DWQVLQALIICPFLL | 341 | A1A5C7 | |
| ICVIWVLALLLAFPQ | 151 | P25103 | |
| FLVCALLLLNPWTAG | 976 | Q9Y6C5 | |
| ILAVVLVFFVCWLPE | 261 | Q99527 | |
| DLICCGAILFPVVWS | 406 | Q9NPR9 | |
| VGFPVLLATVQLWNL | 1556 | Q7Z443 | |
| LVCAVFLLNPWTAGI | 1041 | Q13635 | |
| PVGPWLLALFVFVVC | 36 | Q8N6R1 | |
| FSCTVVLSVLLWLGP | 356 | Q8NG04 | |
| LIEILGAQVPSLPWC | 331 | Q8TE82 | |
| WGLIQPFICTQHLIV | 476 | Q96GZ6 | |
| LLVRDTPFWAGIIVC | 81 | Q14714 | |
| SIWILAFLLAFPQCL | 206 | P29371 | |
| LVLCAWLSGFLTIFP | 141 | Q9NZP0 | |
| VFRLLSVLIPVACVW | 261 | Q6PIS1 | |
| IWSFLGPVCTVIVIN | 751 | Q14246 | |
| LVCTATLAWGVNLPA | 806 | Q8N3C0 | |
| LALVPLCWFANIVVR | 131 | O00501 | |
| LLAGILVLIPVCWTA | 126 | O95484 | |
| LWRCQFLLPFVSLGL | 136 | Q9NY35 | |
| PIWIIIFGVIFCIII | 141 | Q9HBJ8 | |
| LQLAWTPVVVLNGLA | 71 | A0A087X1C5 | |
| IPAGVVCLLSTICLW | 201 | Q6UXD7 | |
| TVGIFWPVLSLCYLI | 356 | P48995 | |
| LDCFVIPVVILLSWF | 161 | Q5T1Q4 | |
| GVTALCWDPVQRVLF | 201 | Q96P53 | |
| SVRIACPIWNGALAI | 41 | A6NML5 | |
| LAFNVWLLLAPVTLC | 321 | Q8IUR5 | |
| LVINFVQLCTLALWP | 26 | Q9NRZ7 | |
| AWKVPTLLALGLFVC | 211 | Q658P3 | |
| LPLLFPVLWVLATAC | 326 | Q12767 | |
| ALLCAVVTGVIWRQP | 536 | P30825 | |
| VVWVGSFFCPLLPLL | 541 | Q7Z404 | |
| GIFNWIIPLSVALSC | 306 | Q9UM01 | |
| FTVWNKCLTIITGLP | 641 | O15344 | |
| RPVLIIFCLCLGWAN | 6 | A0A075B6U4 | |
| TLLEWQDALCFIPVG | 756 | Q12815 | |
| WGVCVSILALLPRVL | 826 | Q9NXF1 | |
| WSTLGVCAALKLPQI | 11 | Q8N755 | |
| FWVQVLLAGLVVPLL | 201 | Q93038 | |
| LAAGAQCVLVSLWPV | 1646 | Q96AY4 | |
| IQVSISVQLWRLPGC | 1881 | Q96AY4 | |
| PFGTLVAILALWFCI | 466 | Q99805 | |
| PLLFISICDVWLQLF | 146 | Q7RTT9 | |
| VCWLPLLVFIAQTVL | 256 | P21731 | |
| LGLWIILVCAVFSGL | 281 | Q1EHB4 | |
| WVAISPLFLLFIICS | 541 | P31645 | |
| RACWFVITPILLIAI | 526 | Q9UN76 | |
| VLFLFICGLLPWIDN | 756 | Q6PJF5 | |
| LGTLGILTVFWVCPL | 296 | Q5GH70 | |
| ILTVFWVCPLTIFNP | 301 | Q5GH70 | |
| GVFWVTFSCIAILIP | 406 | Q9NS93 | |
| VLVIVGLCLWLPSAS | 16 | P19440 | |
| LIWFGCKLVLNPSAI | 126 | Q15049 | |
| FGNCRLLPEAIWIQT | 151 | Q86YQ2 |